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ABSTRACT

STATISTICAL METHODS FOR HIGH DIMENSIONAL
DATA ARISING FROM LARGE EPIDEMIOLOGICAL
STUDIES
MAY 2017
HUI XU
B.Sc., TONGJI UNIVERSITY
M.Sc., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Raji Balasubramanian

In this thesis, we propose statistical models for addressing commonly encountered
data types and study designs in large epidemiologic investigations aimed at understanding the molecular basis of complex disorders. The motivating applications come
from diverse disease areas in Women’s Health, including the study of type II diabetes
in the Women’s Health Initiative (WHI), invasive breast cancer in the Nurses’ Health
Study and the study of the metabolomic underpinnings of cardiovascular disease in
the WHI. We have also put significant effort into making the implementation of the
proposed methods accessible through freely available, user-friendly software packages
in R.
The first chapter is motivated by the self-reported outcomes of incident diabetes
that were collected periodically for approximately 160,000 women enrolled in the
Women’s Health Initiative (WHI). While self-reported outcomes are cost efficient,
v

they are also subject to error. With a goal of variable selection in a high dimensional
data setting, we adapt the Random Survival Forests algorithm to accommodate the
characteristics of error-prone self-reports. We propose a novel likelihood-based splitting rule and associated variable selection algorithm to select the subset of relevant
biomarkers that are associated with the time to event of interest. We compare the
proposed methods to existing approaches in simulation studies. We apply the proposed algorithm to discover single nucleotide polymorphisms associated with incident
type II diabetes risk in a dataset of 909,622 SNPs on 10,832 African American and
Hispanic women. We implement the proposed algorithm in an R package icRSF.
The second chapter is aimed at estimating and evaluating prediction rules in data
generated in matched case control studies that are nested within large prospective
cohorts. This work is motivated by a matched case-control study nested within the
Nurses’ Health Study, where the goal was to determine if the inclusion of a set of
seven endogenous hormone measurements will enhance the predictive ability of breast
cancer risk when compared to the previously published Gail Score. For this setting, we
propose an algorithm for estimating the summary index, area under the curve (AUC)
corresponding to the Receiver Operating Characteristic (ROC) curve associated with
a set of pre-defined covariates for predicting a binary outcome. By combining data
from the parent cohort with that generated in a matched case-control study, we
describe methods for estimation of the population parameters of interest and the
corresponding AUC. We evaluate the bias associated with the proposed methods in
simulations by considering a range of parameter settings. We illustrate the methods
in the motivating study of endogenous hormones and breast cancer risk, nested within
the Nurses’ Health Study.
The third chapter is aimed at estimating and evaluating prediction rules in high
dimensional datasets generated in matched case control studies nested within large
prospective cohorts. In this setting, the goals include simultaneous variable selec-
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tion, estimation of a prediction rule and its corresponding summary index such as the
AUC for quantifying the strength of prediction. This work is motivated by an ongoing
study of metabolomics of cardiovascular disease in the WHI. Through extensive simulations, we compare three disparate variable selection procedures in conjunction with
the parameter estimation and inverse probability weighted estimation of the AUC
proposed in Chapter 2. We also evaluate the extent of overfitting observed when the
multi-step procedure is carried out within one, two and three independent datasets.
The common thread underlying all three chapters of this thesis is the development
and application of statistical models useful in the study of complex disorders, with
illustrative applications drawn from diverse areas of women’s health.
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CHAPTER 1
A MODIFIED RANDOM SURVIVAL FORESTS
ALGORITHM FOR NON-RECURRING, TIME TO EVENT
OUTCOMES IN THE PRESENCE OF IMPERFECT,
SELF-REPORTED OR LABORATORY BASED
DIAGNOSTIC TESTS

1.1

Introduction

Rapid advances in biomedical technology have resulted in a rich array of data
from large prospective studies such as the Women’s Health Initiative (WHI), including extensive behavioral, genotypic, metabolomic and phenotypic information. These
databases are invaluable resources for elucidating the factors governing the etiology
of complex disorders - but in order to use them most effectively, robust methods for
accounting for measurement error in high dimensional datasets need to be developed.
In large, prospective studies like the WHI, the prevalence and incidence of many diseases such as diabetes are determined by self-administered questionnaires, which are
cost-effective and logistically feasible; however, self-reports are imperfect for estimating disease prevalence and incidence. In this paper, we propose a novel algorithm for
assessing variable importance in high dimensional datasets (p >> n) in which a time
to event outcome is observed with error, such as through self-reports.
Consider the onset of a silent event such as Type 2 diabetes, that can only be
detected by administering a diagnostic test. If a perfect diagnostic test is administered
repeatedly, the onset of the disease can be inferred to lie in the interval between the
last negative and first positive diagnostic test - that is, the time to event is interval
censored. However, due to cost considerations, imperfect diagnostic tests or self1

reported outcomes are often used in-lieu of perfect diagnostic tests, especially in largescale epidemiologic studies that follow hundreds of thousands of subjects. Recent
studies indicate that the sensitivity of self-reported diabetes outcomes in the WHI
can range from 45%-60% with a specificity of 99% [42, 41]. A study in a prospective
Finnish cohort showed that the sensitivity of self-reports for incident disease (diabetes,
hypertension, asthma, coronary heart disease and rheumatoid arthritis) was between
55% and 63% [48]. In these settings, analytical approaches that ignore the error
in the observed time to event outcome can result in loss of power and an increased
rate of false discovery [24]. Self-reported outcomes are frequently collected in large,
observational studies and will likely become increasingly more frequent as more cost
effective study designs are considered.
A rich literature exists for analyzing outcomes measured with error. Previous
work in this area includes methods for error-prone outcomes with application to data
collected from laboratory-based diagnostic tests in studies in HIV, HPV and STD
([6, 7, 44, 45]). [7] developed a formal likelihood framework to estimate the distribution of the time to mother to child transmission of HIV. The proposed methods were
applied to data from imperfect DNA PCR diagnostic tests to detect the presence of
HIV in infants who were born to HIV-positive pregnant women. [45] extended the discrete proportional hazard model to incorporate misclassified outcomes and covariates,
when the mis-measurement rates are known. [40] extended this work to handle settings in which mis-measurement rates are unknown and the data includes a validation
set; that is, a subset of individuals for whom the time to event outcome is observed
without error. Several papers proposed generalized Cox models in settings involving
time to event outcomes with incomplete event adjudication ([61, 16, 17]). Other related work includes that proposed by [44] in the context of HPV studies, where the
authors accommodate misclassification by incorporating ideas of binary generalized
linear models with outcomes subject to misclassification ([47]). The problem of error-
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prone time to event outcomes can also be handled through the Hidden Markov Model
(HMM) framework. Previous applications of HMM based methods include in the
areas of breast cancer ([15]), HIV ([59, 25]), lung transplantation ([32]) and cervical
smear tests ([37]). [33] present a general framework for staged Markov models to
handle misclassification due to error-prone screening tests. Other recent methodological advances within the general area of outcomes measured with error include the
papers by [22] and [39]. However, while all these methods account for mis-measured
outcomes, none of them are applicable to high dimensional datasets.
Estimating variable importance in high dimensional data settings has been an
active area of research. Several algorithms have been proposed specifically for time
to event outcomes. Lp shrinkage methods have been extended to accommodate time
to event outcomes, by replacing the observed data likelihood by the Cox partial
likelihood [67, 64]. Other approaches include the use of hierarchical clustering to
reduce the dimensionality of the covariate space, such as the tree harvesting approach
by [28]. Variance based methods such as supervised principal components have also
been proposed ([5, 4]). Random Survival Forests [30] (RSF) is an ensemble treebased algorithm for variable selection in high dimensional datasets, in the presence
of right-censored time to event outcomes. RSF enjoys all the properties of Random
Forests [11] including computational efficiency and good prediction performance with
low generalization error. This algorithm is particularly useful in settings where the
covariate space is characterized by complex inter-relationships including the presence
of interaction effects with respect to the survival outcome. A comprehensive review
of methods for the analysis of high dimensional data applicable to time to event
outcomes can be found in [69].
In this paper, we propose an extension of the RSF algorithm [30] for variable
selection in high dimensional data settings while simultaneously accounting for a
time to event outcome that is measured with error. Our work is motivated by self-
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reported outcomes that are routinely collected in large-scale epidemiologic studies,
such as the WHI [3]. The methods equally apply to settings in which an imperfect, laboratory-based diagnostic test is utilized to assess the occurrence of a silent
event. The proposed algorithm incorporates a formal likelihood framework that accommodates sequentially administered, error-prone self-reports or laboratory based
diagnostic tests [24]. The original RSF algorithm is modified to account for errorprone outcomes by incorporating a new splitting criterion based on a likelihood ratio
test statistic. A new permutation based metric for variable importance is proposed.
In Section 1.2, we introduce notation, form of the likelihood and present the modified RSF algorithm. In Section 1.3, we present simulation studies evaluating the
performance of our proposed algorithm to the original RSF algorithm. Here we separately consider the setting of continuous covariates and categorical covariates such
as in genome-wide association studies (GWAS). In Section 1.4, we apply the proposed methods to a dataset of 88,277 Single Nucleotide Polymorphisms (SNPs) on
a subset of 9,873 women in the WHI Clinical Trial and Observational Study SNP
Health Association Resource (SHARe). The goal of these analyses is to discover the
subset of SNPs that are associated with incidence of type II diabetes. We present a
discussion of future directions and potential limitations of the proposed methods in
Section 1.5. The methods illustrated in this paper have been implemented in an R
software package icRSF, which is available at the Comprehensive R Archive Network
(CRAN) website.

1.2

Methods

In Section 1.2.1, we present notation and the form of the likelihood for time to
event outcomes, in the presence of error-prone, self-reported outcomes. In Section
1.2.2, we describe the steps in the modified RSF algorithm and in Section 1.2.3,

4

we describe the likelihood ratio test based splitting criterion and associated variable
importance metric.

1.2.1

Notation, Likelihood and Estimation

Let X refer to the random variable denoting the unobserved time to event for
an individual, with associated survival, density and hazard functions denoted by
S(x), f (x) and λ(x), for x ≥ 0 respectively. The time origin is set to 0, corresponding
to the baseline visit at which all subjects enrolled in the study are assumed to be
event-free. In other words, Pr(X > 0) = 1. Without loss of generality, we set X = ∞
when the event of interest does not occur. Let N denote the number of subjects
and ni denote the number of visits for the ith subject during the follow-up period.
At each visit, we assume that each subject would self report their disease status as
either positive or negative. For example, at each semi-annual (WHI-CT) or annual
contact (WHI-OS), all participants were asked, “Since the date given on the front of
this form, has a doctor prescribed any of the following pills or treatments?” Choices
included “pills for diabetes” and “insulin shots for diabetes”. Thus, incident treated
diabetes was ascertained, and was defined as a self-report of a new physician diagnosis
of diabetes treated with oral drugs or insulin.
For the ith subject, we let Ri = {Ri1 , · · · , Rini } and ti = {ti1 , · · · , tini } denote
the 1 × ni vectors of self-reported, binary outcomes and corresponding visit times,
respectively. In particular, Rik is equal to 1 if the k th self-report for the ith subject
is positive (indicating occurrence of the event of interest such as diabetes) and 0
otherwise. We assume that self-reports are collected at pre-scheduled visits up to
the time of the first positive self-report - thus, the vectors of test results (Ri ), visit
times (ti ) and the number of self-reports collected per subject (ni ) are random. Let
τ1 , · · · , τJ denote the distinct, ordered visit times in the dataset among N subjects,
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where 0 = τ0 < τ1 < ... < τJ < τJ+1 = ∞ - thus, the time axis can be divided into
J + 1 disjoint intervals, [0, τ1 ), [τ1 , τ2 ), · · · , [τJ , ∞).
The joint probability of the observed data for the ith subject can be expressed as:

g(Ri , ti , ni ) =

J+1
X

Pr(τj−1 < Xi ≤ τj )Pr(Ri , ti , ni | τj−1 < Xi ≤ τj )

j=1

=

J+1
X

θj Pr(Ri , ti , ni | τj−1 < Xi ≤ τj )

j=1

where θj = Pr(τj−1 < X ≤ τj ), τ0 = 0 and τJ+1 = ∞.
To simplify the form of the expression above, we make the assumption that given
the true time of event Xi , an individual’s ni self-reports are independent. That is,

Pr(Ri | Xi , ti ) =

ni
Y

Pr(Rik | Xi , tik )

k=1

This assumption implies that the observed values of other self-reported outcomes do
not provide additional information about the distribution of a particular self-reported
outcome from that provided by the actual time of the event. We note that this
assumption is analogous to the common assumption in measurement error regression
models that the conditional distribution of the response variable, given the covariate
and its proxy, is the same as the conditional distribution given only the covariate. It
can be shown that the joint probability of the observed data for the ith subject can
be simplified as:

g(Ri , ti , ni ) =

J+1
X
j=1

=

J+1
X

θj

"n
i
Y

#
Pr(Rik | τj−1 < Xi ≤ τj , tk )

k=1

θj Cij

j=1

(1.1)
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Q i
where Cij = [ nk=1
Pr(Rik | τj−1 < Xi ≤ τj , tk )] [24]. We assume that the probability
of a positive self-report at the kth visit (Rik = 1) conditional on the interval containing
the true event time and visit time can be expressed as:

Pr(Rik = 1|τj−1 < Xi ≤ τj , tk ) =





ϕ1 ,

tk ≥ τj


 1 − ϕ0 , tk ≤ τj−1
Here, ϕ1 and ϕ0 denote the sensitivity and specificity of self-reports, respectively.
Thus the terms Cij , for j = 1, · · · , J + 1 in equation (1.1) can be expressed as a
product involving the constants ϕ1 and ϕ0 . Thus, in the absence of covariates, the
log likelihood for a random sample of N subjects can be expressed as:

l(θ) = log(L(θ)) =

N
X
i=1

=

N
X
i=1

where Sj = Pr(X > τj−1 ) =

PJ+1
l=j

J+1
X
log(
Cij θj )
j=1
J+1
X
log(
Dij Sj )
j=1

θl . Here, the vector of interval probabilities can be

expressed as θ = Tr S, where Tr is the (J + 1) × (J + 1) transformation matrix and
DN ×(J+1) = C × Tr . For the special case where self-reports are perfect (ϕ1 = ϕ0 = 1),
the likelihood above reduces to the non-parametric likelihood for interval censored
observations given in Turnbull (1976).
In most settings, including the WHI, it is of interest to evaluate the association of
a vector of covariates with respect to the time to event of interest. Let Z denote the
P × 1 vector of covariates with corresponding P × 1 vector of regression coefficients
denoted by β. To incorporate the effect of covariates, we assume the proportional
0

hazards model, λ(x|Z = z) = λ0 (x)ez β , or equivalently, S(x|Z = z) = S0 (x)e

z0 β

.

To derive the form of the log-likelihood based on the assumption of the proportional hazards model, we first re-parameterize the log likelihood in terms of the of
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the survival function, S = (1 = S1 , S2 , · · · , SJ+1 )T , where Sj = p(X > τj−1 ). Since
PJ+1
Sj =
l=j θl , the vector of interval probabilities can be expressed as θ = Tr S,
where Tr is the (J + 1) × (J + 1) transformation matrix. Let C = [Cij ] denote the
N × (J + 1) matrix of the coefficients, Cij , and let the N × (J + 1) matrix D be
defined as DN ×(J+1) = C × Tr . Then, the log-likelihood function for the one-sample
setting can be expressed as

l(S) =

N
X

J+1
X
log(
Dij Sj ),

i=1

(1.2)

j=1

where S1 = 1 and S2 , S3 , · · · , SJ+1 are the unknown parameters of interest.
Let 1 = S1 > S2 > ... > SJ+1 denote the baseline survival functions (i.e. corresponding to Z = 0), evaluated at the left boundaries of the intervals [0, τ1 ), [τ1 , τ2 ), · · · , [τJ , ∞).
(i)

zi0 β

Then, for subject i, with corresponding covariate vector zi , Sj = (Sj )e

. Thus, the

log-likelihood function for a random sample of N subjects in equation (1.2) can be
extended to incorporate covariates as

l(S, β) =

N
X

J+1
X
z0 β
log(
Dij (Sj )e i ).

i=1

(1.3)

j=1

The elements of the D matrix are functions of the observed data including the visit
times, the corresponding self-reported results (ti , Ri for i = 1, · · · , ni ), and the constants ϕ0 , ϕ1 . Assuming that ϕ0 , ϕ1 are known, the maximum likelihood estimates
of the unknown parameters β1 , · · · , βP , S2 , · · · , SJ+1 can be obtained by numerical
maximization of the log-likelihood function in equation (1.3), subject to the constraints that 1 > S2 > S3 > · · · > SJ+1 > 0. Statistical inference regarding the
parameters of interest (β1 , · · · , βP , S2 , · · · , SJ+1 ) can be made by using asymptotic
properties of the maximum likelihood estimators ([18]). The estimated covariance
matrix of the maximum likelihood estimates can be obtained by inverting the Hes-
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sian matrix. Hypothesis tests regarding the unknown parameters can be carried out
using the likelihood ratio or Wald test.

1.2.2

Modified Random Survival Forests (RSF)

We describe the key steps involved in implementing the modified RSF algorithm
for error-prone self-reported outcomes. The details regarding the splitting criterion
and estimation of variable importance are described in Section 1.2.3.
1. Draw b = 1, · · · , B bootstrap samples of size N from the original data. As is
typical of the bootstrap procedure, we expect that on average

1
3

of the data will

be excluded - this subset is denoted as the out-of-bag (OOB) sample.
2. Corresponding to each bootstrap sample, grow a survival tree. At each node of
the tree, randomly select a user-defined number of candidate variables, p∗ < P .
Among the subset of p∗ variables, select the variable and corresponding value
of split that maximizes the likelihood ratio test splitting criterion (see Section
1.2.3). Split the parent node into two daughter nodes based on the selected
variable and its splitting value.
3. Grow the tree to full size until the number of subjects in the terminal node
is equal to or fewer than a user defined parameter, M . In this process, the
tree separates dissimilar subjects into distinct terminal nodes - thus, each terminal node will include a homogenous subset of subjects with respect to the
distribution of the time to event of interest.
4. For each tree corresponding to each bootstrap sample (b = 1, · · · , B), calculate
the OOB log likelihood, lb . The value of the OOB log likelihood is used to
calculate a permutation based variable importance metric (See Section 1.2.4 for
details). Use the variable importance metric to rank variables from most to
least important with regard to its association with the time-to-event outcome.
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1.2.3

Node Splitting Criterion and Variable Importance

Here we describe our proposed criterion for splitting nodes in a survival tree and
an associated measure of variable importance.
1. Criterion for splitting nodes:
As in CART, survival trees are binary trees grown by recursive splitting of
parent nodes. At each node of a tree, subjects are assigned to one of two
daughter nodes by a split on a variable Z and associated threshold c, such that
the resulting daughter nodes have maximal difference in outcome. Assume that
a specific node includes N ∗ subjects and that p∗ < P variables are randomly
selected as candidate variables for splitting the node into two daughter nodes.
The process of splitting this parent node into two daughter nodes is based on
identifying the variable and its splitting value that maximizes the likelihood
ratio test statistic criterion described below:
For each candidate variable Zk and a corresponding splitting value ck , we defined
a new random variable Zk∗ = 1 if Zk < ck and Zk∗ = 0, otherwise. We obtain the
maximized value of the log likelihood for all N ∗ subjects, based on the PH model
including Zk∗ as the single covariate, with corresponding regression coefficient
βk∗ (Equation (1.3)). We compare this full model to the null model (without
Zk∗ ) and obtain the value of the likelihood ratio test statistic for testing the null
hypothesis H0 : βk∗ = 0. The random variable corresponding to the best split
∗
∗
(denoted Zm
with associated regression coefficient βm
) is found by searching

over all p∗ candidate covariates and all possible splitting values to find that
which maximizes the likelihood ratio test statistic. We note that for continuous
covariates, this step is implemented by searching over a user-defined grid of
possible splitting values.
Comparison to original RSF: The proposed splitting criterion differs significantly from that in the RSF algorithm - the randomSurvivalForest R software
10

package includes three variations of the log rank splitting rule as well as a conservation of events splitting rule [29]. While these approaches are appropriate
for right censored event times, they do not allow for error in the outcome as is
characteristic of self-reports.
2. Variable importance:
∗
, S2 , S2 , . . . , SJ+1 ) are estimated by
At each node, the unknown parameters (βm

maximizing the log likelihood shown in Equation (1.3) that incorporates the
∗
covariate Zm
. For every survival tree in the ensemble, a value of log-likelihood

based on the OOB sample (lb , for b = 1, · · · , B) is calculated as follows: Subject i in the OOB sample of tree b is dropped down the tree and assigned a
terminal node. Let lib denote the log likelihood contribution for subject i in
the OOB sample for tree b. The value of lib is calculated based on the log
∗
, Ŝ2 , Ŝ2 , . . . , ŜJ+1 ) obtained
likelihood in Equation (1.3), using parameters (β̂m

at the immediate parent of the terminal node to which subject i is assigned.
The log-likelihood for tree b (lb ) is obtained as the sum of the log-likelihood
P
contributions of all subjects in the OOB sample - that is, lb = i∈ OOB lib .
We obtain a measure of variable importance for each variable Zk by permuting
its values, while all other variables remain as in the original dataset. Following
a random permutation of variable Zk , the value of the OOB log-likelihood ˜lbk is
calculated, for every tree b = 1 · · · B based on the OOB sample. The variable
importance for Zk is calculated as:

V IM Pk =

B
X

n
o
˜
max (lb − lbk ), 0

(1.4)

b=1

Average values of V IM Pk are reported for each covariate k, by averaging over
multiple permutations of Zk . Larger values of V IM Pk indicate that the covariate Zk has strong association with the outcome.
11

Comparison to original RSF: In the original RSF algorithm, variable importance
for each variable x is obtained as the difference between the average prediction error
of the ensemble based on randomized x assignments from the prediction error of the
original ensemble. Prediction error is calculated from the Harrell’s concordance index
corresponding to the cumulative hazard function estimated for each subject in the
dataset.

1.3

Simulation

To motivate the proposed algorithm, we illustrate the degradation in the variable
selection performance of the original RSF algorithm, with increasing error in the
self-reported outcomes (See Supplement, Appendix A). In Sections 1.3.1 - 1.3.3, we
present results from three simulation studies considering different variable types to
compare the performance of our proposed modified RSF algorithm to the original
RSF algorithm proposed by Ishwaran, H. et al (2008).
Simulation set-up: Each simulated dataset included N = 100 subjects and P =
100 covariates, of which the first five (Z1 , · · · , Z5 ) were assumed to be true biomarkers. We assumed that the true time to event followed an exponential distribution
and that the set of five biomarkers influenced the outcome through a proportional
hazards model. We note that the exponential distribution assumption is only used
to set the values of the parameters S2 , · · · , SJ+1 and is not an assumption of the
proposed approach. Let λ0 denote the hazard corresponding to the reference group
(corresponding to Z1 = · · · = Z5 = 0). Under the proportional hazards model,
the hazard for a subject with arbitrary values of the covariates Z1 , · · · , Z5 is given
by λZ1 ,Z2 ,Z3 ,Z4 ,Z5 = λ0 eβ1 Z1 +β2 Z2 +β3 Z3 +β4 Z4 +β5 Z5 . The regression coefficients β1 , · · · , β5
were all assumed to be equal and set to 2. The hazard function for the reference group
λ0 was varied such that the cumulative incidence rates during the four year follow-up
period were 0.1 and 0.3, respectively. We assumed that the duration of follow-up
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was 4 years and that there were annual visits at which self-reported outcomes were
collected. We considered four settings of (sensitivity, specificity) for self-reported
outcomes: (1.00, 1.00), (0.75, 1.00), (0.60, 0.99), (1.00, 0.9) as well as two study
designs - the first, in which there were no missed visits; the second, in which no
further visits are scheduled following the first positive self-report. For each subject
i, binary self-reported outcomes at each visit at years 1-4 (Ri1 , · · · , Ri4 ) were simulated by assuming specific values for the sensitivity and specificity of self-reports.
For example, assume that the time-to-event for subject i is Xi = 2.5 years, the
sensitivity and specificity of self-reported outcomes are ϕ1 = 0.9 and ϕ0 = 0.7, respectively. Then, the self-reported outcomes at visits 1-4 are simulated according
to P(Ri1 = 1 | Xi = 2.5, ti1 = 1) = P(Ri2 = 1 | Xi = 2.5, ti2 = 2) = 1 − ϕ0 and
P(Ri3 = 1 | Xi = 2.5, ti3 = 3) = P(Ri4 = 1 | Xi = 2.5, ti4 = 4) = ϕ1 .
The datasets were analyzed using the original RSF, using the R package randomForestSRC [31] and the modified RSF algorithm. The 100 variables were ranked from
most to least important based on: (1) variable importance from RSF; and (2) variable
importance from modified RSF. The top five ranking variables by each metric were
considered as “discovered biomarkers”. The average proportion of datasetes in which
each of the five true biomarkers was discovered (p̂) and its associate standard error
q
(SE = 1.96 ∗ p̂(1−p̂)
) was calculated for each metric.
100
1.3.1

Simulation: Continuous covariates

The 100 covariates per subject were simulated as independent, Gaussian random
variables with mean 0 and unit variance. Table 1.1 presents the average proportion of
datasets in which the five true biomarkers were ranked among the top five variables,
by each variable importance metric. We present results for both study designs, that
is (1) No missing data; and (2) Missing all data following the first positive self-report.
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When there is no missing data and when specificity is close to perfect (ϕ0 =
0.99, 1.00), the proportion of datasets in which the true biomarkers are discovered by
RSF is comparable to that by the modified RSF algorithm. Figure 1(a) shows a bar
plot of the average variable importance (across 100 datasets) by modified RSF, for
the setting in which 1 − SJ+1 = 0.10, ϕ1 = 0.60, ϕ0 = 0.99 and no missed visits, .
The average variable importance for each of the five true biomarkers is more than six
times larger than that of a covariate not associated with outcome (noise).
On the other hand, when specificity is low, our proposed algorithm achieves significantly better performance when compared to RSF. For example, when the cumulative
incidence is 10%, sensitivity is 1.00 and specificity is 0.90, each of the top five biomarkers is discovered by the original and modified RSF algorithms with probabilities 0.52
(SE = ±0.05) and 0.76 (SE = ±0.04), respectively. A similarly improved performance by the modified RSF algorithm was observed when the cumulative incidence
was larger (1 − SJ+1 = 0.30). However, when we assumed that no follow-up data
are collected following the first positive self-report, the modified RSF algorithm did
not achieve any statistically significant improvement in variable selection performance
when compared to the original RSF algorithm. This highlights the loss of information
that occurs when data collection ceases following the first positive self-report, in settings where the specificity is less than perfect. In all settings considered, the average
probability of being “discovered” for one of the 95 non-biomarkers did not exceed
0.03 (SE = ±0.02) and was comparable between both the original and modified RSF
algorithms.

1.3.2

Simulation: Genome-wide Association Study (GWAS)

To incorporate the structure of data observed in a GWAS study, we fixed the
100×100 design matrix of covariates to equal a randomly sampled subset of the GWAS
data in the WHI Clinical Trials and Observational Study SHARe. We randomly
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selected 100 out 10,832 subjects and 100 out of 909,622 SNPs available in the dataset.
Of the 100 selected SNPs, 53 SNPs had Minor Allele Frequencies (MAF) values ≤ 0.35
and 47 had MAF (0.35, 0.50]. For computational efficiency, each SNP was converted
into a binary variable by coding the ‘AA’ genotype as 0, the ‘Aa’ as 2 and ‘aa’
genotypes as 1. In each simulation, five of the 100 SNPs were randomly selected to be
the true biomarkers with β = 1. Tables 1.2 and 1.3 present the average proportions of
simulated datasets in which the five true biomarkers were ‘discovered’, for the settings
of (1) No missing data and (2) Missing all data following the first positive self-report,
respectively. In each table, we separately report the results for biomarkers (SNPs)
with MAF in the ranges (0.00, 0.35] and (0.35, 0.50].
As expected, across all settings both algorithms were better able to discover
biomarkers that have a higher MAF when compared to biomarkers with lower MAF.
As in the simulations with the continuous covariates, when no follow-up data are
collected following the first positive self-report, the modified RSF algorithm and the
original RSF algorithm achieve similar performance with respect to the probability
of discovering true biomarkers. Figure 1.1(b) shows a bar plot of the variable importance metric by modified RSF for a representative simulated dataset, for the setting
in which 1 − SJ+1 = 0.10, ϕ1 = 0.60, ϕ0 = 0.99 and no missed visits - the variable
importance metrics were not averaged across simulations as the identity of the five
true biomarkers varied randomly between simulated datasets. ‘Blue’ indicates true
biomarkers with MAF ∈ (0.35, 0.50] and‘red’ indicates true biomarkers with MAF ∈
(0.00, 0.35]. As expected, true biomarkers with MAF ∈ (0.35, 0.50] were more likely
to rank higher than true biomarkers with MAF ∈ (0.00, 0.35].
However, when there is no missing data and when specificity is less than perfect
(ϕ0 = 0.90), we observed significantly improved performance by the modified algorithm when compared to the original algorithm. For example, when the cumulative
incidence of events is 10%, ϕ0 = 0.90 and ϕ1 = 1.00, and biomarkers have MAF in the
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range (0, 0.35], each biomarker is discovered by the original and modified RSF algorithms with probabilities 0.34 (SE = ±0.047) and 0.56 (SE = ±0.050), respectively.
When biomarkers have MAF in the range (0.35, 0.50], each biomarker is discovered
by the original and modified RSF algorithms with probabilities 0.44 (SE = ±0.050)
and 0.70 (SE = ±0.046), respectively.

1.3.3

Simulation: Cardiovascular Disease Omics Study

We incorporated data from a cardiovascular disease ‘omics’ study that was conducted to discover prognostic biomarkers in blood plasma for near-term cardiovascular
events. Subjects were selected from the CATHGEN project, which collected peripheral blood samples from consenting research subjects undergoing cardiac catheterization at Duke University Medical Center from 2001 through 2011. 68 cases were selected from among individuals who had a major adverse cardiac event (MACE) within
two years following the time of their sample collection. In a 1:1 matched study design,
68 controls were selected from individuals who were MACE-free for the two years following sample collection and were matched to cases on age, gender, race/ethnicity
and severity of coronary artery disease. High-content mass spectrometry and multiplexed immunoassay-based techniques were employed to quantify 625 proteins and
metabolites from each subject’s serum specimen. Comprehensive metabolite profiling
of the individual samples was based on a combination of four platforms employing
mass spectrometry (MS) based techniques to profile lipids, fatty acids, amino acids,
sugars and other metabolites. Proteomic analysis was based on a combination of targeted methods using a quantitative multiplexed immunoassay technique as well as a
comprehensive protein profiling strategy based on tandem mass spectrometry. A detailed description of the mass spectrometry based platforms and proteomics analysis
can be found in a previous publication [26].
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To incorporate the structure of observed data, we selected a random subset of
100 out the 625 covariates for all 136 subjects - of these, 5 were selected to represent
the set of ‘true’ biomarkers, each with β = 1. Each of the 100 covariates were

standardized to render them with mean 0 and unit variance. The 100
pairwise
2
Pearson’s correlations between covariate pairs ranged from -0.54 to 1.0 (IQR [-0.07,
0.16]), exhibiting the complex dependence structure commonly observed in ‘omics’
datasets (Figure A.2 of Supplement). The pairwise correlations between the five true
biomarkers ranged from -0.22 to 0.20. Each of the five biomarkers also exhibited
varying marginal distributions, as seen in Figure A.3 of the Supplement.
Table 1.4 presents the average proportions of simulated datasets in which the five
true biomarkers were ‘discovered’, for the settings of (1) No missing data and (2)
Missing all data following the first positive self-report, respectively. As in previous
simulations, when no follow-up data are collected following the first positive selfreport, the modified RSF algorithm and the original RSF algorithm achieved similar
performance. When there is no missing data and when specificity is less than perfect (ϕ0 = 0.90), we observed significantly improved performance by the modified
RSF algorithm when compared to the original RSF algorithm. For example, when
the cumulative incidence of events is 10%, ϕ0 = 0.90 and ϕ1 = 1.0, the average
probability of being discovered by the original and modified RSF algorithms were
0.46 (SE = ±0.05) and 0.70 (SE = ±0.05), respectively. Figure 1(c) shows a bar
plot of average variable importance, when 1 − SJ+1 = 0.10, ϕ1 = 0.60, ϕ0 = 0.99
and there are no missed visits. The bars corresponding to the first five variables
shown in red correspond to the true biomarkers. Average variable importance for the
five biomarkers varied considerably, reflecting the differences in the shapes of their
marginal distributions (Figure A.3 of Appendix A).
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1.4

Application

We analyzed data from the WHI Clinical Trial and Observational Study SHARe,
which includes data on 909,622 SNPs on 10,832 African American and Hispanic
women. Prevalent and incident Type 2 diabetes were determined by self-reports
collected at annual (WHI Observational Study) or semi-annual (WHI Clinical Trials)
visits. Incident treated diabetes was ascertained by a positive self-report of a new
physician diagnosis of diabetes treated with oral drugs or insulin. No further information was collected with regard to a new diabetes diagnosis following the first positive
self-report. We illustrate the application of our proposed algorithm using this dataset
to identify SNPs associated with incident diabetes.
Data pre-processing: Individuals who self-reported diabetes at baseline were excluded (N=959). The analysis dataset included 9,873 subjects from the following
race/ethnicity groups - African Americans (N=6,704), Hispanic Americans (N=3,169).
We included follow-up until 2015, resulting in a median duration of follow-up of 12
years including 108,197 person-years of total follow-up. During the course of followup, 20.34% of women self-reported incident diabetes.
We follow a multi-step procedure to filter the GWAS dataset that included 909,622
SNPs. First, SNPs that meet at least one of the following criteria were excluded from
our analysis: 1) greater than 1% of missing values (68,176 SNPs); 2) MAF below 5%
(63,019 SNPs); 3) a Hardy-Weinberg equilibrium test p-value less than 0.05 (467,735
SNPs). We carried out a set of univariate analyses to test the association if each
remaining SNP with incident diabetes, while adjusting for population substructure.
To quantify the extent of genetic variability that is explained by race/ethnicity, we
carried out a principal components analysis and extracted the top two principal components that accounted for 1.88% and 0.48% of the total variability, respectively ([53];
[62]). The association of each SNP with incident diabetes was evaluated by fitting a
model based on the likelihood in equation (1.3) ([23]; [24]). P values from a likeli-
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hood ratio test were calculated and SNPs with p > 0.20 were excluded from analysis.
Following these filtering procedures, we included 88,277 SNPs in our analysis.
Methods: The analysis dataset included 88,277 SNPs on 9,873 subjects. The
analyses were run by allowing three levels for each SNP, that is, ‘ AA’ , ‘Aa’, ‘aa’. All
missing entries are imputed assuming the major allele. The analysis adjusted for the
top two principal components to correct for population stratification and included the
following potential confounders: smoking status, alcohol intake, age, education, WHI
study, BMI, recreational physical activity, dietary energy intake, family history of
diabetes, and hormone therapy use. The baseline characteristics of the 9,873 subjects
is described in Table A.1 in the Appendix A. The ranking of individual SNPs was
assessed by the following methods:
1. Univariate Cox Proportional Hazards (PH) model: Statistical significance of
each SNP is assessed individually, while adjusting for population stratification
and other confounders. The time to event was calculated as the time between
the enrollment date and the date of the first positive self-report (observed event),
or the date of last contact (censored observation). The SNPs were ranked
according to the Wald test p-value of the null hypothesis of no association
between the SNP and incident diabetes.
2. RSF: This multivariable analysis was based on the original RSF algorithm [30]
using the R package randomForestSRC [31]. The input to the algorithm included
the set of 88,277 SNPs as well as the top two principal components (to adjust
for population stratification) and potential confounders. The time to event
outcome is defined as in the Cox PH model. A survival forest of 1000 trees
was built with a node splitting criterion based on the log rank test. SNPs were
ranked according to a variable importance metric obtained as the difference in
the cumulative hazard function before and after permutation.
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3. Modified RSF: This multivariable analysis was based on the proposed algorithm
using the R package icRSF [70] based on the input of the set of 88,277 SNPs
as well as the top two principal components (to adjust for population stratification) and potential confounders. The sensitivity and specificity of self-reported
diabetes were assumed to be 0.61 and 0.995, respectively ([42]; [24]). A survival
forest of 1000 trees was built and the minimum terminal node size was fixed at 5
subjects. SNPs were ranked according to a variable importance metric obtained
as the difference in the OOB log-likelihood before and after permutation.
Results: Figure 1.2 shows a bar plot of the variable importance of each SNP (1
through 88,277), including a horizontal dashed line indicating the variable importance
threshold separating the top 10 SNPs from the rest. SNPs that were found to rank
among the top 10 most important by at least one of the above analyses are shown
in Table 1.5. Each SNP is annotated with its host gene (if known) and the left and
right flanking genes.
A total of 27 SNPs were identified in the top 10 by at least one of the three
strategies, while simultaneously adjusting for population stratification and potential
confounding by other factors. We examined the degree of linkage disequilibrium (LD)
between all pairs of the 27 SNPs in Table 1.5 - only 1 pair of SNPs was found to have
r2 values of 0.05 or larger.
Three SNPs (rs16997235, rs10126793, rs16917265) were ranked among the top 50
by all three strategies. Three SNPS (rs639724, rs2805429, rs2924928) were ranked
among top 2 by two strategies. In addition, several SNPs among the top 10 by the
modified RSF algorithm were not detected among the top 1000 by the other two
approaches. For example, the top SNPs identified by the modified RSF algorithm
(rs10777370, rs7187364, rs17627111) had ranks above 1000 by RSF. The left gene
of SNP rs10777370 (DCN) and host gene of rs7187364 (WWOX) have both previously been implicated as a risk allele for Type 2 diabetes [10, 58]. The host gene of
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rs17627111 (ESRRG) wAS previously known to be associated with type 2 diabetes
within African Americans ([46])). Several other genes that either contain or flank the
SNPs identified among the top 10 by at least one analysis have been previously found
to be implicated in Type 2 diabetes (Table 1.6).

1.5

Discussion

In this paper, we propose an ensemble tree based algorithm for variable selection in
high dimensional datasets, in settings where a time to event outcome is observed with
error. The models developed in this paper are motivated by imperfect, self-reported
outcomes of incident type 2 diabetes collected in the Women’s Health Initiative. The
proposed methods apply to other settings in which the event of interest is diagnosed
using an imperfect laboratory-based diagnostic test that is given at prescheduled
times during follow-up.
We presented results from simulations, considering different data types and a
variety of settings with regard to cumulative incidence of event during the study and
sensitivity/specificity of the self-report (or imperfect diagnostic test). We compared
the performance of our proposed algorithm to RSF ([30], which assumes that outcomes
are observed without error. We considered datasets in which continuous variables are
measured as well as datasets typically seen in GWAS studies. When studies collect
self-reports or test results according to a predetermined schedule and when specificity
is less than perfect, our proposed algorithm has a significantly better performance with
regard to variable selection when compared to the original RSF algorithm. In studies
where collection of self-reports or diagnostic test results ceases after the first positive
result, our modified algorithm no longer performs better than RSF. We applied the
proposed algorithm to data from the WHI Clinical Trial and Observational Study
SHARe. Several genes associated with top ranking SNPs were found to be related to
the risk of type 2 diabetes in the literature (Table 1.6).
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The proposed algorithm assumes that the values of sensitivity and specificity of
the self-reported outcomes/diagnostic tests are constant. In some applications, these
could depend on demographic variables and change over time. In other settings, the
sensitivity/specificity parameters could be unknown and require estimation. For these
applications, it would be useful to extend the proposed methods.
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No missing data

Missing all data following first
positive self-report
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1 − Sj+1

ϕ1

ϕ0

pRSF

p1

pRSF

p1

0.10

1.00

1.00

0.736(±0.0441)

0.812(±0.0391)

0.736(±0.0441)

0.786(±0.0410)

0.75

1.00

0.716(±0.0451)

0.748(±0.0434)

0.716(±0.0451)

0.768(±0.0422)

0.61 0.995

0.636(±0.0481)

0.684(±0.0465)

0.636(±0.0481)

0.712(±0.0453)

1.00

0.90

0.518(±0.0500)

0.760(±0.0427)

0.518(±0.0500)

0.586(±0.0493)

1.00

1.00

0.792(±0.0406)

0.828(±0.0377)

0.792(±0.0406)

0.850(±0.0357)

0.75

1.00

0.764(±0.0425)

0.794(±0.0404)

0.764(±0.0425)

0.794(±0.0404)

0.61 0.995

0.686(±0.0464)

0.708(±0.0455)

0.686(±0.0464)

0.736(±0.0441)

1.00

0.620(±0.0485)

0.814(±0.0389)

0.620(±0.0485)

0.670(±0.0470)

0.30

0.90

Table 1.1: Simulation - Continuous covariates: The average proportion of datasets (±SE) in which the five true biomarkers are
ranked among the top five according to three measures of variable importance, namely (1) original RSF algorithm (pRSF ); and
(2) variable importance from the modified RSF algorithm (p1 ). 1 − SJ+1 , ϕ1 , ϕ0 denote the cumulative incidence in the reference
group, sensitivity and specificity, respectively.

No missing data
M AF ∈ (0, 0.35]

M AF ∈ (0.35, 0.5]
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1 − Sj+1

ϕ1

ϕ0

pRSF

p1

pRSF

p1

0.10

1.00

1.00

0.578(±0.0494)

0.560(±0.0496)

0.725(±0.0447)

0.701(±0.0458)

0.75

1.00

0.575(±0.0494)

0.566(±0.0496)

0.702(±0.0457)

0.710(±0.0454)

0.61

0.995

0.487(±0.0500)

0.511(±0.0500)

0.594(±0.0491)

0.657(±0.0475)

1.00

0.90

0.339(±0.0473)

0.556(±0.0497)

0.435(±0.0496)

0.703(±0.0457)

1.00

1.00

0.619(±0.0486)

0.623(±0.0485)

0.737(±0.0440)

0.754(±0.0431)

0.75

1.00

0.607(±0.0488)

0.578(±0.0494)

0.688(±0.0463)

0.692(±0.0462)

0.61

0.995

0.529(±0.0499)

0.526(±0.0499)

0.571(±0.0495)

0.654(±0.0476)

1.00

0.90

0.427(±0.0495)

0.563(±0.0496)

0.533(±0.0499)

0.767(±0.0423)

0.30

Table 1.2: Simulation - Genome-wide association study (GWAS): The average proportion of datasets (±SE) in which the five
true biomarkers are ranked among the top five according to two measures of variable importance, namely (1) original RSF
algorithm (pRSF ), and (2) variable importance from the modified RSF algorithm (p1 ). 1 − SJ+1 , ϕ1 , ϕ0 denote the cumulative
incidence in the reference group, sensitivity and specificity, respectively. The results are stratified by Minor Allele Frequency
categories of (0, 0.35] and (0.35, 0.5]. We assume the setting of no missed visits.

Missing all data following first positive self-report
M AF ∈ (0, 0.35]

M AF ∈ (0.35, 0.5]
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1 − Sj+1

ϕ1

ϕ0

pRSF

p1

pRSF

p1

0.10

1.00

1.00

0.578(±0.0494)

0.586(±0.0493)

0.725(±0.0447)

0.704(±0.0456)

0.75

1.00

0.575(±0.0494)

0.569(±0.0495)

0.702(±0.0457)

0.706(±0.0456)

0.61

0.995

0.487(±0.0500)

0.510(±0.0500)

0.594(±0.0491)

0.635(±0.0481)

1.00

0.90

0.339(±0.0473)

0.313(±0.0464)

0.435(±0.0496)

0.463(±0.0499)

1.00

1.00

0.619(±0.0486)

0.600(±0.0490)

0.737(±0.0440)

0.753(±0.0431)

0.75

1.00

0.607(±0.0488)

0.580(±0.0494)

0.688(±0.0463)

0.710(±0.0454)

0.61

0.995

0.529(±0.0499)

0.528(±0.0499)

0.571(±0.0495)

0.672(±0.0469)

1.00

0.90

0.427(±0.0495)

0.465(±0.0499)

0.533(±0.0499)

0.605(±0.0489)

0.30

Table 1.3: Simulation - Genome-wide association study (GWAS): The average proportion of datasets (±SE) in which the five
true biomarkers are ranked among the top five according to two measures of variable importance, namely (1) original RSF
algorithm (pRSF ), and (2) variable importance from the modified RSF algorithm (p1 ). 1 − SJ+1 , ϕ1 , ϕ0 denote the cumulative
incidence in the reference group, sensitivity and specificity, respectively. The results are stratified by Minor Allele Frequency
categories of (0, 0.35] and (0.35, 0.5]. We assume that all visits following the first positive self-report are missing.

No missing data

Missing all data following first
positive self-report
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1 − Sj+1

ϕ1

ϕ0

pRSF

p1

pRSF

p1

0.10

1.00

1.00

0.692(±0.0462)

0.700(±0.0458)

0.692(±0.0462)

0.728(±0.0445)

0.75

1.00

0.634(±0.0482)

0.722(±0.0448)

0.634(±0.0482)

0.736(±0.0441)

0.61 0.995

0.574(±0.0494)

0.702(±0.0457)

0.574(±0.0494)

0.706(±0.0456)

1.00

0.90

0.464(±0.0499)

0.698(±0.0459)

0.464(±0.0499)

0.534(±0.0499)

1.00

1.00

0.778(±0.0416)

0.752(±0.0432)

0.778(±0.0416)

0.772(±0.0420)

0.75

1.00

0.742(±0.0438)

0.76(±0.0427)

0.742(±0.0438)

0.772(±0.0420)

0.61 0.995

0.700(±0.0458)

0.744(±0.0436)

0.700(±0.0458)

0.738(±0.0438)

1.00

0.654(±0.0476)

0.748(±0.0434)

0.654(±0.0476)

0.638(±0.0481)

0.30

0.90

Table 1.4: Simulation - Cardiovascular Disease Omics Study: The average proportion of datasets (±SE) in which the five
true biomarkers are ranked among the top five according to three measures of variable importance, namely (1) original RSF
algorithm (pRSF ); and (2) variable importance from the modified RSF algorithm (p1 ). 1 − SJ+1 , ϕ1 , ϕ0 denote the cumulative
incidence in the reference group, sensitivity and specificity, respectively.

SNPs

Gene

Left Gene

Right Gene

rs10777370

DCN

BTG1

rs639724

LOC100130372

LOC284749

rs16983007
rs7187364

WWOX

LOC645947

LOC729251

rs2805429

RYR2

MT1P2

LOC100130331

rs10733596

SNX30

C9orf80

SLC46A2

rs16997235
rs17087990
rs17627111

ESRRG

ATXN8OS

DACH1

USH2A

GPATCH2

rs10126793
rs16917265
rs16991792

LOC731957

rs1277957

Cox PH

RSF

modified RSF

102

> 1000

1

> 1000

31

2

715

> 1000

3

615

> 1000

4

4

> 1000

5

246

> 1000

6

26

4

7

151

> 1000

8

> 1000

> 1000

9

15

20

10

C9orf80

SNX30

1

1

47

SYN3

LARGE

7

> 1000

248

EFNB1

PJA1

> 1000

2

392

rs10859620

HERC3

LOC100129137

NAP1L5

30

9

> 1000

rs1457586

ZNF385D

VENTXP7

LOC728516

2

156

> 1000

6

528

> 1000

rs17300926
LOC728095

CCDC99

> 1000

3

> 1000

EDIL3

LOC391807

> 1000

5

> 1000

FHIT

LOC100128936

> 1000

6

> 1000

rs9345756

ADH5P4

NUFIP1P

> 1000

7

> 1000

rs7762347

LOC100131805

LOC100129616

> 1000

8

> 1000

rs6553479

LOC402192

LOC100131470

> 1000

10

> 1000

rs17555633

SLIT3

rs7707956
rs2365943

PTPRG

rs2805434

RYR2

MT1P2

LOC100130331

3

> 1000

> 1000

rs137299

LOC731957

SYN3

LARGE

5

> 1000

> 1000

rs286588

MRPS35P1

MRPS36P1

8

> 1000

> 1000

rs11769851

tcag7.955

LOC442727

9

> 1000

> 1000

NUDT5

CAMK1D

10

> 1000

> 1000

rs1317548

CDC123

Table 1.5: Rankings of individual SNPs in the WHI Clinical Trial and Observational
Study SHARe from the following analyses: (1) Univariate Cox PH model; (2) RSF;
(3) modified RSF. Each analysis simultaneously adjusted for all potential confounding
variables as well as the top two principal components to account for population stratification. SNPs are ordered from most (rank= 1) to least important (rank > 1000)
with regard to their association with time to incident Type 2 diabetes.
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Gene Symbol
DCN
WWOX
RYR2*
DACH1*
ESRRG*
USH2A
GPATCH2*
CDC123

Association Type
Biomarker
Genetic Variation
Biomarker
Biomarker
Biomarker, Genetic
Biomarker, Genetic
Biomarker, Genetic
Biomarker, Genetic

Variation
Variation
Variation
Variation

PubMed Example
[10]
[58]
[49, 19]
[43]
[46]
[71]
[46]
[21]

Table 1.6: Genes selected by the modified RSF algorithm that were reported to be
related to risk of type 2 diabetes in previous literature. * indicates genes that were
reported to be associated with type 2 diabetes in African Americans or Hispanic
Americans.
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X1
X2
X3
X4
X5
X6
X7
X8
X9
X10
X11
X12
X13
X14
X15
X16
X17
X18
X19
X20
X21
X22
X23
X24
X25
X26
X27
X28
X29
X30
X31
X32
X33
X34
X35
X36
X37
X38
X39
X40
X41
X42
X43
X44
X45
X46
X47
X48
X49
X50
X51
X52
X53
X54
X55
X56
X57
X58
X59
X60
X61
X62
X63
X64
X65
X66
X67
X68
X69
X70
X71
X72
X73
X74
X75
X76
X77
X78
X79
X80
X81
X82
X83
X84
X85
X86
X87
X88
X89
X90
X91
X92
X93
X94
X95
X96
X97
X98
X99
X100
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X59
X60
X61
X62
X63
X64
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X69
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X71
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X74
X75
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Figure 1.1. Variable importance from modified Random Survival Forests: Barplot
of variable importance for each of 100 covariates, considering the setting in which
1 − SJ+1 = 0.10, ϕ1 = 0.61, ϕ0 = 0.995 and there are no missed visits. (a) Continuous
covariates - average variable importance over 100 simulated datasets is shown, where
the first five (shown in red) represent the true biomarkers. (b) GWAS data - variable
importance for a representative simulation is shown (results are not averaged as the
identity of the true biomarkers varies between simulations). ’Blue’ indicates true
biomarkers with MAF ∈ (0.35, 0.5] and‘red’ indicates true biomarkers with MAF ∈
(0, 0.35]. (c) Omics data - average variable importance over 100 simulated datasets
is shown, where the first five (shown in red) represent the true biomarkers.
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Figure 1.2. Women’s Health Initiative Genome-wide association study (GWAS) of incident, Type II diabetes: Barplot of
variable importance for each of 88,277 SNPs. The horizontal dashed line indicates the threshold of selecting top 10 SNPs.

CHAPTER 2
ESTIMATING THE RECEIVER OPERATING
CHARACTERISTIC CURVE IN MATCHED CASE
CONTROL STUDIES

2.1

Introduction

The matched case-control study design is widely utilized in biomedical investigations. Matching of cases to controls on one or more confounders can result in significant gains in efficiency ([57, 38, 56]). Case control studies are often nested within a
large prospective cohort, and are useful when the outcome of interest is rare. In many
settings, the measurement of the biomarker(s) on all individuals in a prospective cohort is prohibitively expensive. This study design enables researchers to balance the
number of cases and controls within matching strata defined by previously known
confounding factors and to collect biomarker measurements only on the selected subset of subjects. While matched studies are primarily geared toward estimation of the
association between exposure (or biomarker) and outcome, prediction in this setting
is not straightforward. In this paper, we describe an inverse-probability weighting
approach to estimate the area under the curve (AUC) associated with the Receiver
Operating Characteristic (ROC) curve in a matched case control study. We consider
settings in which the aim is to estimate the predictive ability of a pre-defined set of
covariates that could include both novel biomarkers in conjunction with traditional
risk factors with respect to a binary outcome.
In a typical matched case control study, all or a subset of cases are randomly
selected from a prospective cohort. Each selected case is matched to one or more
randomly selected controls on confounding factors such as age, gender etc. - and
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this selection results in a sample of controls that is no longer representative of the
population. This also implies that statistical analysis of a matched case control study
has to take the matching into account. An unmatched analysis of matched data can
result in biased estimates of the biomarker-outcome association ([56], [60]). Conditional logistic regression models are commonly employed to estimate the magnitude
and significance of the association of one or more biomarkers with an outcome ([12],
[2]). The statement of the conditional logistic regression model includes matching
stratum-specific intercepts. However, in this model, the association of a biomarker
with outcome is estimated by maximization of the conditional likelihood, which eliminates the stratum-specific intercepts as nuisance parameters. Since these models do
not provide estimates of the stratum specific intercepts, they are not appropriate for
direct estimation of prediction and related statistics.
The accuracy of classification of cases and controls according to an algorithm can
be visualized through a ROC curve. However, direct estimation of the ROC curve
using data from matched case control studies can result in estimates that are attenuated toward the null [51]. Several papers in the literature have described the use and
estimation of the covariate adjusted ROC curve (AROC), which is a measure of the
covariate adjusted classification accuracy and is useful for evaluating the predictive
ability of a new biomarker ([52, 35, 34, 36]). Other related work in the literature
include methods for estimating the ROC curve and associated summary indices using
data from nested case control studies ([13, 14, 73]). Our proposed methods build
upon the work by [54], who proposed a multiple step likelihood-based approach for
parameter estimation and prediction in matched case-control studies. In this paper, the authors describe methods for estimating the effects of matching factors and
biomarkers in a matched case control study by augmenting the data collected in the
matched study with information from the parent cohort. We extend the methods
from [54] for estimation of the ROC curve associated with a pre-defined set of covari-
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ates by incorporating an inverse-probability weighting procedure that accounts for
the non-random sampling of controls in the matched study.
The paper is structured as follows: In Section 2.2 we introduce notation, describe
the approach for parameter estimation and the calculation of matching stratum specific weights for ROC and AUC estimation. In Section 2.3 we present results from
extensive simulation studies and compare the performance of the proposed approach
to AUC estimation to naive methods based on conditional logistic regression and logistic regression. In Section 2.4, we apply our proposed methods to data generated in
a breast cancer study of 437 patient cases and 775 matched controls nested within the
Nurses’ Health Study (([66]). In Section 2.5, we discuss limitations of the proposed
approach and consider extensions to related settings.

2.2

Method

In section 2.2.1, we present the notation and define the population model. In
section 2.2.2, we briefly summarize the approaches to obtain unbiased estimates of the
parameters governing the population model ([54]). In sections 2.2.3-2.2.4, we propose
a weighted estimator of the AUC that adjusts for the distortion of the prevalence of
cases to controls within covariate strata as a result of matching. In section 2.2.5, we
describe a bootstrap sampling procedure for estimating the standard error (SE) of
the AUC estimator.

2.2.1

Notation

Let Y denote a binary response variable (1=case, 0=control), X = (X1 , . . . , Xp )T
denote a 1×p vector of biomarkers and other variables of interest and Z = (Z1 , . . . , Zq )T
denote a 1 × q vector of variables used in matching. We assume the following logistic
regression model at the population level to describe the association of outcome (Y )
with biomarkers X and matching variables Z:
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logit(P r(Y = 1|X, Z) = α + β T X + γ T Z

(2.1)

where β = (β1 , . . . , βp )T and γ = (γ1 , . . . , γq )T . We assume that the primary parameters of interest are β.
As in a typical 1 : m matched case control study, we assume that N subjects
are enrolled such that each case is matched to m controls based on the matching
variables, Z. In this setting, we assume that all or a random sample of the cases in
the population are included in the study, with selection of controls according to the
matching by variables Z. To implement the matching, we assume that the matching
variables Z are used to create K matching strata.
Here, we describe the procedure for estimation of the parameters α, β, γ governing
the population logistic regression model in Equation (2.1) based on the methods
proposed in [54].
Let V denote the binary variable indicating if a subject is sampled into the
matched case-control study (i.e. 1=yes, 0=no). We assume that given (Y, Z), the
sampling probability does not depend on X. In other words, P r(V = 1 | Y, Z, X) =
P r(V = 1 | Y, Z). In a 1 : m matched case control study design, the following holds:

P r(Y = 1 | V = 1, Z) =

P r(Y = 0 | V = 1, Z)
m

Thus, under 1 : m matching, it follows that
P (Y = 1|Z, X, V = 1)
P (Y = 1|Z, X) P (Y = 0|Z)
1
=
×
× .
P (Y = 0|Z, X, V = 1)
P (Y = 0|Z, X) P (Y = 1|Z) m
Therefore, from (2.1), the probability that a case is sampled into the matched casecontrol study is

logit P (Y = 1|X, Z, V = 1) = α + f (Z) + β T X + γ T Z
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(2.2)

o
n
=0|Z)
- log(m). The term f (Z) plays an important role in
where f (Z) = log PP (Y
(Y =1|Z)
the estimation of α and γ ([54]).
According to the methods described in [54], we summarize both the Two-stage
procedure and Simultaneous procedures for estimation of the parameters, β, γ in the
population logistic regression model (2.1).
1. Estimating the offset, f (Z): To estimate f (Z), we use data from the parent
cohort study and fit a logistic regression model treating Y as the outcome and
n
o
(Y =0|Z)
Z as the predictors of interest. By obtaining the estimate of log PP (Y
=1|Z)
n
o
(Y =0|Z)
from the logistic regression model, the offset f (Z) = log PP (Y
- log(m) is
=1|Z)
estimated.
2. Two-stage procedure: According to this algorithm, β and α, γ are estimated in
two separate steps.
(a) Estimating β: Using the data from the 1 : m matched case control study,
we fit a conditional logistic regression model by including the biomarkers
X as predictors and obtain maximum likelihood estimates of β.
(b) Estimating α, γ: Using the data from the matched case control study, we
fit a logistic regression model where Y is the outcome and Z the vector of
ˆ + β̂X estimated
predictors, while simultaneously including the offset f (Z)
in the previous step.
3. Simultaneous procedure: According to this algorithm, β, α, γ are estimated
together in one model. As shown in equation (2.2), by including the offset f (Z)
, β, α, γ can be simultaneously estimated in a logistic regression model fit to
the matched case control study data.
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2.2.2

Sampling weights

As discussed in the literature ([35, 34, 52]), direct estimation of the AUC using
data from matched case control studies can result in severely biased estimates. This
phenomenon is driven by the fact that the selected set of controls are no longer
representative of a random sample from the population; therefore, AUC estimates can
be severely biased especially in settings in which the biomarker is strongly correlated
with the matching variables. For example, in a biomarker studies, one often matches
on fasting status, which can be related to the levels of one or more biomarkers.
Within each matching strata 1 · · · , K based on Z, we propose an inverse probability weighting approach to obtain a weighted AUC estimator. The proposed weights
are implemented with the goal of recovering the stratum specific relative proportion
of cases and controls in the original cohort.
Let p0k , p1k denote the proportions of controls and cases in the k th matching
stratum, where p0k + p1k = 1. In a well designed matched case control study that is
nested within a prospective cohort, the proportions of controls in each of the K strata
(p01 , · · · , p0K ) should be directly estimable. The proposed weights for each case and
control within the k th stratum are:
p0k
p0k
=
wk,case = 1 ; wk,control =
m ∗ p1k
m ∗ (1 − p0k )
In a 1 : m matched case control study, let jk and m × jk denote the number
of cases and controls in the k th matching stratum. The proposed weights (wk,case ,
wk,control ) can be shown to result in the relative proportion of cases to controls of
p1k /p0k , since after weighting, the following holds:
1
1 + p0k /p1k
p0k /p1k
Proportion of controls =
.
1 + p0k /p1k
Proportion of cases =

36

2.2.3

Weighted AUC estimator

We propose the following algorithm to estimate the AUC incorporating the effects
of the matching variables Z and biomarkers X:
1. Estimate parameters α, β, γ in the population logistic model as described in
Section 2.2.1.
2. For each subject in the matched case control study, the linear score Ŝ = α̂ +
β̂X + γ̂Z is calculated.
3. The weights (wk,case , wk,control ) for each subject in the matched case control
study is calculated, as described in Section 2.2.2.
4. Using estimated linear score, the weighted ROC curve and associated AUC is
calculated as follows:
Let S = {S1 , · · · , SN } denote the linear score based on the population logistic
model (Equation (2.1)), for each subject 1, · · · , N in the matched case control
study. As described in [50], we define a binary test for predicting outcome Y
using a threshold s as:

Predict Y = 1 if S ≥ s
Predict Y = 0 otherwise

For each threshold s, let T P F (s) = P r(S ≥ s | Y = 1) and F P F (s) =
P r(S ≥ s | Y = 0) denote the true positive fraction and false positive fraction,
respectively. The corresponding estimates from the matched case control study,
adjusting for the weights are:
P

wi ∗ 1[Ŝi ≥ s]
P
i:Yi =1 wi

P

wi ∗ 1[Ŝi ≥ s]
P
.
i:Yi =0 wi

i:Yi =1

T Pd
F (s) =

i:Yi =0

F Pd
F (s) =
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The associated area under the curve is calculated from the weighted ROC curve.

2.2.4

Confidence intervals

We propose a bootstrap sampling procedure for estimating the SE of the AUC
estimate and associated confidence intervals for the AUC.
1. Obtain b bootstrap samples, each generated by sampling the matched sets with
replacement. We note that this bootstrap sampling procedure ensures that the
matched structure of the original dataset is preserved.
Based on the bth bootstrap sample:
(a) Estimate α, β, γ as described in Section 2.2.2. We note that the offset
fd
(Z) is that based on the parent cohort and does not need to be estimated
in each bootstrap sample.
(b) Using the weights calculated from the parent cohort, re-estimate the AUC
based on the procedure described in Section 2.2.4
2. Obtain the desired confidence interval based on the percentiles of the distribution of the AUC estimates from the b bootstrap samples.
In the Appendix D, we compared the bootstrap estimates of SE to estimates of SE
from multiple simulated datasets and found close agreement.

2.3

Simulation

We present results from simulation studies considering a range of parameter values corresponding to the population logistic regression model. Through simulations,
we compare the performance of naive estimators of AUC using logistic and conditional logistic regression models to the proposed weighted AUC estimator presented
in Section 2.2.
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2.3.1

Simulation strategy

of
√
Based on 100 simulations, averages (AU C) and SEs ( standard deviation
100

dC
AU

)

are reported. In each dataset, we estimate the AUC according to the following strategies.
• Logistic regression: We fit a logistic regression based on Equation (2.1) to the
matched case-control dataset (ignoring the matching) and obtain β̂, α̂ and γ̂.
Using the estimated linear predictor (α̂ + β̂X + γ̂Z), we obtain both unweighted
and weighted AUC estimates.
• Conditional logistic regression: We fit conditional logistic regression using the
matched case control dataset, treating Y as the outcome and X as the predictor
in the model and estimate β̂. Using the estimated linear predictor (β̂X) as the
prediction score, we obtain both unweighted and weighted AUC estimates. Note
that in this process, we implicitly set α̂ = γ̂ = 0 when estimating the linear
predictor.
• Proposed estimators: Based on the procedure described in Section 2.2, we estimate α, γ, β using either the Two-stage or Simultaneous approaches for parameter estimation ([54]). Using the estimated linear predictor (α̂ + β̂X + γ̂Z), we
obtain both unweighted and weighted AUC estimates.
Data generation: For each setting, we simulate data (Y, Z, X) for a large number
of subjects (e.g. N = 10000) of a hypothetical population assuming the population
logistic regression model in Equation (2.1). From the simulated population, we draw
a matched case control dataset of size n, by matching on the variable Z.
Binary matching variable, Z: For all subjects in the population, we simulate
a matching variable Z, where Z ∼ Bernoulli(0.5) and the biomarker X as follows:
X | Z = 0 ∼ N (0, 1) and X | Z = 1 ∼ N (δ, 1). Here, δ represents the parameter
quantifying the shift in mean levels of biomarker X, through Z. By setting values
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of the parameters α, β, γ, we calculate the linear predictor as α + βX + γZ and
corresponding values of the P r(Y = 1 | X, Z) for each subject. We simulate the
outcome Y for each subject as a Bernoulli random variable with probability p =
P r(Y = 1 | X, Z). From the simulated population, a matched case control study of
size n is drawn as follows: A random sample of cases (Y = 1) of size n is selected.
For each selected case, a matching control (Y = 0) is selected, such that the case and
its matched control have the same value of Z.
Continuous matching variable, Z: To generate the large population dataset, we
simulate a matching variable Z, where Z ∼ N (µ = 0, σ 2 = 1.5). Z is categorized into
10 strata (denoted W ) according to deciles of its distribution. For all subjects in the
population, we simulate the biomarker X ∼ N (ρW, σ 2 = 1 − ρ2 ). Here, ρ represents
the parameter quantifying the effect of the matching variable Z (or equivalently W )
on the biomarker X, through both its mean and variance. The random variable
Y is simulated as described above and a matched case control dataset is drawn by
matching on W .
Parameter values: In all simulations, we fix β = 0.5. We consider different
strengths of the effect of the matching variable Z with respect to Y by varying the
value of γ = {0, 0.25, 0.50, 0.75}. In the simulations involving a binary matching variable, we vary δ between the values δ = 0, 0.5, 1. In the setting involving a continuous
matching variable, we vary ρ between the values ρ = {0, 0.35, 0.7}. We set the number
of matched pairs to n = 100. Results for n = 250 are presented in Appendix C. In
each simulation scenario, we fix α such that the prevalence of cases in the population
is 10%.

2.3.2

Results: Binary matching variable

Figure 2.1 presents estimates of bias (SE) associated with estimates of AUC,
comparing both the naive estimates of AUC to weighted estimates. Figures 2.3-2.3
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present estimates of bias (SE) associated with estimates of β, γ, based on logistic
regression (LR), conditional logistic regression (CLR) and the proposed methods for
parameter estimation (Section 2.2). See Tables 2.1-2.3 for estimates of β, γ, AUC and
associated SE for each parameter setting, assuming that the size of the matched case
control study is n = 100 case-control pairs.
When γ = δ = 0, the matching variable Z has no effect on the outcome Y either
directly through the logistic model in Equation (2.1) or through the biomarker X.
In this setting, the sampled sets of cases and controls in the study are equivalent to
random samples from the population of all cases and controls - and thus weighted
and unweighted estimates from all three approaches (logistic regression, conditional
logistic regression and proposed strategy) result in unbiased estimates of the true
AUC (Figure 2.1, Table 2.1).
When δ = 0, γ > 0, the matching variable Z has a direct effect on the outcome
Y through the logistic model in Equation (2.1) - however, in this case, the matching
variable Z is independent of the biomarker, X. Here, the matched sampling of controls into the study is no longer equivalent to selecting a random sample of controls.
Moreover, estimation of the linear predictor requires unbiased estimates of parameters
α, β, γ. When estimation of parameters is based on the conditional logistic regression
model, we set α̂ = γ̂ = 0, resulting in biased estimates of the linear predictor. When
δ = 0, γ > 0, estimates of γ, β based on the proposed procedure are nearly unbiased
(Figures 2.2-2.3) - however, the unweighted AUC estimate is biased towards the null,
reflecting the skewed sampling of controls into the study. On the other hand, the
weighted AUC estimate based on the proposed methods that accounts for the biased
sampling procedure is unbiased when δ = 0 and for varying values of γ (Figure 2.1,
Table 2.1).
When δ > 0 and γ > 0, the matching variable Z has both a direct effect on Y
through the logistic model (Equation (2.1)) and an indirect effect on Y through it’s

41

association with biomarker X. For example, consider the setting when β = 0.5, δ =
1.0, γ = 0.75, resulting in a true AUC of 0.71. The weighted AUC estimates based on
both the Two-stage and Simultaneous procedures was 0.71 (95% CI: 0.708 - 0.717).
All other approaches showed modest to large bias towards the null (Figure 2.1, Tables
2.2-2.3).
Figures 2.2-2.3 show that estimates of β, γ are unbiased under both Simultaneous
and Two-stage parameter estimation strategies. Results for a larger sample size of
n = 250 matched pairs are shown in Appendix C Tables C.1-C.3 and Figures C.1-C.3
had identical trends.

2.3.3

Results: Continuous matching variable

Figure 2.4 presents estimates of bias (SE) associated with estimates of AUC,
comparing both the naive estimates of AUC to weighted estimates. Figures 2.5-2.6
present estimates of bias (SE) associated with estimates of β, γ, based on logistic
regression (LR), conditional logistic regression (CLR) and the proposed parameter
estimation (Section 2.2). Web Tables 2.4-2.6 present the estimates of β, γ, AUC and
associated SE for each parameter setting, when n = 100 case-control pairs.
As in the binary matching variable setting, when γ = ρ = 0, the sampled sets of
cases and controls in the study are equivalent to random samples from the population
of all cases and controls - and thus weighted and unweighted estimates from all three
approaches (logistic regression, conditional logistic regression and proposed strategy)
result in unbiased estimates of the true AUC (Figure 2.4, Table 2.4). When ρ and
γ are large, estimates of β and γ from the Simultaneous approach show significant
bias (Figures 2.5-2.6) when compared to that from the Two-stage method. Moreover,
for settings where γ is large, estimates of γ from the Two-stage shows a modest
residual bias - this result is likely due to the fact that the matching is based on the
discretized variable W , but the population logistic regression model is a function of the
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continuous variable Z. For a continuous matching variable that has strong effects on
outcome and the biomarker, the proposed Two-stage approach incorporating inverseprobability weights achieves minimum bias with respect to AUC and parameters β, γ.

2.4

Application: Nurses’ Health Study

We illustrate our algorithm using data from a matched case control study of 437
cases with breast cancer and 775 controls, nested within the Nurses’ Health Study.
The aims of this study were to evaluate whether the inclusion of seven endogenous
hormones (plasma estradiol, estrone, estrone sulfate, testosterone, dehydro epiandrosterone sulfate (DHEAS), prolactin, and sex hormone-binding globulin (SHBG)) improved risk prediction for postmenopausal invasive breast cancer. While breast cancer
risk-prediction models have been developed to identify women at high risk, these models have not previously included endogenous hormone levels, which are risk factors
for postmenopausal breast cancer.

Study Population: The Nurses’ Health Study was initiated in 1976 with a cohort
of 121,700 US female registered nurses age 30-55 years. Women completed a baseline
questionnaire and have been observed biennially by questionnaire to update exposure
status and disease diagnoses. From 1989 to 1990, 32,826 participants (age 43 to 69
years) provided blood samples ([27]). From 2000 to 2002, 18,743 women provided
a second blood sample (age 53 to 80 years) ([72]). Follow-up of the blood cohort
was 97% in 2010. This study was approved by the Committee on the Use of Human
Subjects in Research at Brigham and Women’s Hospital (Boston, MA). Patient cases,
who were postmenopausal and not using hormone therapy (HT) at time of first blood
draw, were diagnosed with invasive breast cancer after the initial blood collection but
before June 1, 2010, and were matched to one or two controls on birth year (± 2
years), month (± 1 month) and time of day (± 2 hours) of blood draw and fasting (<
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8 or ≥ 8 hours). Endogenous hormones were measured from blood samples collected
at the time of the first blood draw during 1989 to 1990. In total, 437 patient cases
and 775 controls with data on all seven hormones (plasma estradiol, estrone, estrone
sulfate, testosterone, DHEAS, prolactin, SHBG) and the variables included in the
Gail risk prediction model for breast cancer were included in the analysis ([66]).
Data analysis: The measurements of each of seven endogenous hormones in the
matched case control study were log2 transformed prior to inclusion in the analysis. As
reported in [66], each of the seven individual hormones was significantly associated
with invasive breast cancer risk in logistic regression models, while adjusting for
matching factors. Using stepwise regression with adjustment for matching factors,
three of the seven endogenous hormones remained statistically significant - namely
estrone sulfate, testosterone and prolactin. In our analysis, we estimated the AUC
associated with this set of three hormones in combination with the Gail score and
matching factors.
The estimates of β corresponding to estrone sulfate, testosterone and prolactin
were obtained from a conditional logistic regression model in the dataset of 437 patient
cases and 775 matched controls. The offset f (Z) was estimated based on the parent
cohort, after excluding women who were pre-menopausal and using hormone therapy
(HT). The offset f (Z) was estimated using 12, 506 subjects in the Nurses’ Health
Study, of whom 774 were breast cancer cases. The parameter estimates α, γ were
estimated by fitting a logistic regression model to the data from matched case control
b + Gail score in the model. A 95%
study, while controlling for the term fd
(Z) + βX
confidence interval (CI) for the AUC associated with the set of three hormones, Gail
score and matching factors was based on the percentiles of 250 estimates obtained in
bootstrap samples.
Results: In conditional logistic regression models including the three hormones,
the odds ratios for a doubling of hormone levels were 1.33 (95% CI: 1.17 - 1.51), 1.15
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(95% CI: 0.96 - 1.37), and 1.22 (95% CI: 1.02 - 1.46), for estrone sulfate, testosterone
and prolactin, respectively. In the parent cohort, the offset f (Z) was estimated in a
logistic regression model including all matching factors - of these factors, only time
of blood draw was a statistically significant predictor of breast cancer risk. Timing
of blood draw between 1pm-12am was associated with an odds ratio of 1.32 (95% CI:
1.06 - 1.65), compared to the reference time interval of 8am - 12pm. Age at blood
draw was not statistically significant, possibly due to restricting the study to include
only post menopausal women.
The estimates of the parameters γ associated with the matching factors were
estimated in the matched case control dataset, by including f (Z) + β̂X + Gail Score
as an offset. In this model, age remained insignificant, but timing of blood draw
remained statistically significant. The AUC associated with the model including all
three hormones while simultaneously adjusting for the Gail score and matching factors
was 0.602 (95% CI: 0.565-0.640). In comparison, for the same model, the unweighted
AUC estimate was 0.609 (95%: 0.577 - 0.642). The results from our proposed methods
show close agreement with that reported in [66], in which the authors report an AUC
of 0.608 (95% CI: 0.575 - 0.641) for the model with three hormones adjusting for the
Gail score which includes age at menarche, history of previous breast biopsies, age at
first birth, number of first-degree relatives with a history of breast cancer, and age.
Based on trends observed in the simulations, we note that when the matching factors
are neither strongly associated with outcome nor correlated with the biomarkers, the
estimates from proposed methods show close agreement with standard methods based
on logistic regression.

2.5

Discussion

In the context of a matched case control study, we propose an inverse-probability
weighting procedure in combination with the parametworoger2014ter estimation ap-
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proaches described by [54] to estimate the AUC associated with a pre-defined set
of covariates in predicting a binary outcome. The proposed methods are evaluated
in simulations and illustrated with application to breast cancer risk prediction in a
matched case control study nested within the Nurses’ Health Study ([66]). In this
study, we applied the proposed algorithm to estimate the AUC associated with a set
of three endogenous hormones in combination with matching factors (including age)
in predicting invasive breast cancer risk.
The proposed algorithm was evaluated in a series of simulation studies in which
the effects of several factors was manipulated including: (1) the strength of association of matching factors with outcome; (2) the correlation between matching factors
and biomarkers; and (3) sample size. We compared the bias associated with the proposed methods to estimates obtained without weighting and from prediction scores
obtained from logistic regression models that adjust for the matching factors. Our
proposed procedure was the only approach that achieved nearly unbiased estimates
of the AUC, when there is a strong effect of the matching variables with respect to
outcome and/or high correlation between biomarkers and matching variables - these
conditions reflect those in which a matched study design is most appropriate. Moreover, in settings of a continuous matching variable, simulation results showed that
the proposed weighted AUC estimator based on the Two-stage parameter estimation approach showed smaller bias when compared to the Simultaneous parameter
estimation approach.
The proposed methods were developed for hypothesis driven studies in which a
pre-defined set of covariates are evaluated with respect to a binary outcome. Matched
case control studies are also frequently conducted in investigations employing high
throughput metabolomic and proteomic technologies, in which a large number of
measurements are made in each subject. It will be useful to extend methods for AUC
estimation in high dimensional data settings in which a biomarker discovery and val-
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idation procedure precedes model development and prediction.
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Model

β

γ

δ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.5
0.25

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

0.5194
0.5106
0.5106
0.5194
0.5432
0.5370
0.5370
0.5432
0.5104
0.5232
0.5232
0.5104
0.5168
0.5239
0.5239
0.5168

0.0115
0
0.0123
0.0129
0.0136
0
0.2546
0.2542
0.0139
0
0.4802
0.4793
0.0270
0
0.7257
0.7266

0.6410
0.6410
0.6410
0.6410
0.6460
0.6460
0.6460
0.6460
0.6558
0.6558
0.6558
0.6558
0.6706
0.6706
0.6706
0.6706

ˆ C (SE)
AU
Unweighted
Weighted
0.6387 (0.0033)
0.6389 (0.0034)
0.6385( 0.0034)
0.6389 (0.0034)
0.6363 (0.0034)
0.6412 (0.0034)
0.6366 (0.0034)
0.6414 (0.0034)
0.6436 (0.0039)
0.6436 (0.0039)
0.6430 (0.0039)
0.6423 (0.0039)
0.6385 (0.0040)
0.6499 (0.0037)
0.6386 (0.0040)
0.6501 (0.0037)
0.6369 (0.0038)
0.6370 (0.0038)
0.6365 (0.0038)
0.6357 (0.0038)
0.6239 (0.0043)
0.6531 (0.0036)
0.6235 (0.0042)
0.6531 (0.0036)
0.6365 (0.0037)
0.6358 (0.0038)
0.6361 (0.0037)
0.6325 (0.0040)
0.6146 (0.0043)
0.6684 (0.0031)
0.6145 (0.0042)
0.6684 (0.0031)

Table 2.1: Binary matching variable: Estimates (standard error) of AUC, β, γ, comparing logistic regression regression (LR), conditional logistic regression (CLR) and
proposed methods (Two-stage and Simultaneous). AUC estimates using naive and
weighted estimators are compared. Results based on 100 matched case control pairs
and δ = 0.
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Model

β

γ

δ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.75
0.75

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0.5432
0.5370
0.5370
0.5432
0.5104
0.5232
0.5232
0.5104
0.5168
0.5239
0.5239
0.5168
0.5226
0.5305
0.5305
0.5226

-0.0258
0
-0.0139
-0.0173
-0.2413
0
0.2186
0.2241
-0.2314
0
0.4638
0.4682
-0.2209
0
0.7216
0.7252

0.6460
0.6460
0.6460
0.6460
0.6558
0.6558
0.6558
0.6558
0.6706
0.6706
0.6706
0.6706
0.6900
0.6900
0.6900
0.6900

ˆ C (SE)
AU
Unweighted
Weighted
0.6436 (0.0039)
0.6436 (0.0039)
0.6394 (0.0038)
0.6464 (0.0038)
0.6385 (0.0040)
0.6499 (0.0037)
0.6386 (0.0040)
0.6501 (0.0037)
0.6369 (0.0038)
0.6370 (0.0038)
0.6334 (0.0037)
0.6475 (0.0037)
0.6239 (0.0043)
0.6531 (0.0036)
0.6235 (0.0042)
0.6531 (0.0036)
0.6365 (0.0037)
0.6358 (0.0038)
0.6332 (0.0036)
0.6519 (0.0038)
0.6146 (0.0043)
0.6684 (0.0031)
0.6145 (0.0042)
0.6684 (0.0031)
0.6396 (0.0037)
0.6395 (0.0041)
0.6373 (0.0036)
0.6616 (0.0040)
0.6099 (0.0039)
0.6900 (0.0029)
0.6097 (0.0039)
0.6901 (0.0029)

Table 2.2: Binary matching variable: Estimates (standard error) of AUC, β, γ, comparing logistic regression regression (LR), conditional logistic regression (CLR) and
proposed methods (Two-stage and Simultaneous). AUC estimates using naive and
weighted estimators are compared. Results based on 100 matched case control pairs
and δ = 0.5.
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Model

β

γ

δ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.75
0.75

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

0.5104
0.5232
0.5232
0.5104
0.5073
0.5200
0.5200
0.5073
0.5353
0.5465
0.5465
0.5353
0.5289
0.5319
0.5319
0.5289

-0.4965
0
-0.0431
-0.0311
-0.4737
0
0.2239
0.2349
-0.4973
0
0.4516
0.4636
-0.4839
0
0.7109
0.7134

0.6558
0.6558
0.6558
0.6558
0.6721
0.6721
0.6721
0.6721
0.6912
0.6912
0.6912
0.6912
0.7101
0.7101
0.7101
0.7101

ˆ C (SE)
AU
Unweighted
Weighted
0.6369 (0.0038)
0.6370 (0.0038)
0.5237 (0.0035)
0.6506 (0.0036)
0.6239 (0.0043)
0.6531 (0.0036)
0.6235 (0.0042)
0.6531 (0.0036)
0.6358 (0.0042)
0.6360 (0.0042)
0.6242 (0.0038)
0.6633 (0.0038)
0.6131 (0.0046)
0.6686 (0.0035)
0.6128 (0.0046)
0.6687 (0.0035)
0.6428 (0.0039)
0.6411 (0.0041)
0.6318 (0.0036)
0.6799 (0.0037)
0.6140 (0.0041)
0.6920 (0.0032)
0.6134 (0.0041)
0.6922 (0.0032)
0.6407 (0.0036)
0.6415 (0.0037)
0.6318 (0.0035)
0.6931 (0.0032)
0.6067 (0.0037)
0.7124 (0.0024)
0.6065 (0.0037)
0.7125 (0.0024)

Table 2.3: Binary matching variable: Estimates (standard error) of AUC, β, γ, comparing logistic regression regression (LR), conditional logistic regression (CLR) and
proposed methods (Two-stage and Simultaneous). AUC estimates using naive and
weighted estimators are compared. Results based on 100 matched case control pairs
and δ = 1.
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Model

β

γ

ρ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.5
0.5

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

0.5212
0.5225
0.5225
0.5212
0.5104
0.5058
0.5058
0.5104
0.5362
0.5347
0.5347
0.5362
0.5227
0.5223
0.5223
0.5227

0.0015
0
0.0060
0.0060
0.0194
0
0.2653
0.2656
0.0491
0
0.5341
0.5343
0.0860
0
0.8044
0.8046

0.6401
0.6401
0.6401
0.6401
0.6706
0.6706
0.6706
0.6706
0.7310
0.7310
0.7310
0.7310
0.7882
0.7882
0.7882
0.7882

ˆ C (SE)
AU
Unweighted
Weighted
0.6396 (0.0039)
0.6398 (0.0039)
0.6391( 0.0038)
0.6394 (0.0039)
0.6383 (0.0039)
0.6409 (0.0039)
0.6384 (0.0039)
0.6410 (0.0039)
0.6383 (0.0039)
0.6416 (0.0040)
0.6373 (0.0039)
0.6347 (0.0041)
0.6133 (0.0041)
0.6696 (0.0034)
0.6135 (0.0041)
0.6697 (0.0034)
0.6444 (0.0036)
0.6582 (0.0039)
0.6424(0.0036)
0.6319 (0.0043)
0.5949 (0.0037)
0.7324 (0.0027)
0.5955 (0.0036)
0.7325 (0.0027)
0.6405 (0.0036)
0.6878 (0.0030)
0.6367 (0.0037)
0.6271 (0.0055)
0.5815 (0.0031)
0.7816 (0.0023)
0.5818 (0.003)
0.7819 (0.0023)

Table 2.4: Continuous matching variable: Estimates (standard error) of AUC, β, γ,
comparing logistic regression regression (LR), conditional logistic regression (CLR)
and proposed methods (Two-stage and Simultaneous). AUC estimates using naive
and weighted estimators are compared. Results based on 100 matched case control
pairs and ρ = 0.
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Model

β

γ

ρ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.75
0.75

0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35
0.35

0.4817
0.5228
0.5228
0.4817
0.4602
0.5194
0.5194
0.4602
0.4528
0.5291
0.5291
0.4528
0.4387
0.5320
0.5320
0.4387

-0.3044
0
0.0166
0.0094
-0.2485
0
0.2638
0.2974
-0.1898
0
0.5418
0.5811
-0.1322
0
0.8395
0.8837

0.6859
0.6859
0.6859
0.6859
0.7483
0.7483
0.7483
0.7483
0.8024
0.8024
0.8024
0.8024
0.8486
0.8486
0.8486
0.8486

ˆ C (SE)
AU
Unweighted
Weighted
0.6231 (0.0039)
0.6362 (0.0042)
0.5902 (0.0027)
0.6828 (0.0030)
0.5928 (0.0040)
0.6850 (0.0030)
0.5901 (0.0040)
0.6852 (0.003)
0.6210 (0.0041)
0.6605 (0.0050)
0.5993 (0.0032)
0.7369 (0.0033)
0.5760 (0.0037)
0.7470 (0.0027)
0.5714 (0.0035)
0.7466 (0.0026)
0.6201 (0.0037)
0.7008 (0.0043)
0.6088 (0.0032)
0.7680 (0.0030)
0.5714 (0.0030)
0.7908 (0.0023)
0.5654 (0.0029)
0.7902 (0.0023)
0.6174 (0.0039)
0.7435 (0.0045)
0.6109 (0.0036)
0.7843 (0.0037)
0.5694 (0.0028)
0.8217 (0.0024)
0.5627 (0.0026)
0.8209 (0.0024)

Table 2.5: Continuous matching variable: Estimates (standard error) of AUC, β, γ,
comparing logistic regression regression (LR), conditional logistic regression (CLR)
and proposed methods (Two-stage and Simultaneous weighted estimates). AUC estimates using naive and weighted estimators are compared. Results based on 100
matched case control pairs and ρ = 0.35.
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Model

β

γ

ρ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.75
0.75

0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7

0.3580
0.5547
0.5547
0.3580
0.3201
0.5357
0.5357
0.3201
0.2765
0.5405
0.5405
0.2765
0.2505
0.5397
0.5397
0.2505

-0.4243
0
-0.0557
0.1778
-0.3351
0
0.2562
0.4909
-0.2199
0
0.5766
0.8412
-0.1488
0
0.8740
1.1429

0.7604
0.7604
0.7604
0.7604
0.8137
0.8137
0.8137
0.8137
0.8567
0.8567
0.8567
0.8567
0.8881
0.8881
0.8881
0.8881

ˆ C (SE)
AU
Unweighted
Weighted
0.5886 (0.0036)
0.6653 (0.0051)
0.5489 (0.0018)
0.7516 (0.0049)
0.5540 (0.0032)
0.7566 (0.0022)
0.5410 (0.0027)
0.7547 (0.0021)
0.5809 (0.0036)
0.7055 (0.0059)
0.5537 (0.0023)
0.7858 (0.0057)
0.5465 (0.0031)
0.7932 (0.0026)
0.5334 (0.0024)
0.7910 (0.0026)
0.5722 (0.0031)
0.7556 (0.0049)
0.5591 (0.0022)
0.8105 (0.0029)
0.5448 (0.0020)
0.8156 (0.0027)
0.5310 (0.0014)
0.8126 (0.0028)
0.5709 (0.0034)
0.7952 (0.0043)
0.5622 (0.0025)
0.8303 (0.0026)
0.5456 (0.0020)
0.8408 (0.0022)
0.5332(0.0015)
0.8380 (0.0023)

Table 2.6: Continuous matching variable: Estimates (standard error) of AUC, β, γ,
comparing logistic regression regression (LR), conditional logistic regression (CLR)
and proposed methods (Two-stage and Simultaneous weighted estimates). AUC estimates using naive and weighted estimators are compared. Results based on 100
matched case control pairs and ρ = 0.70.
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AUC
n=100 matched pairs
1a. LR−Weighted

1b. LR−Unweighted

2a. CLR−Weighted

2b. CLR−Unweighted

0.00
−0.04
−0.08

Bias in estimate of AUC

0.00
−0.04
−0.08

factor(delta)
0
3a. Two stage−Weighted

3b. Two stage−Unweighted

0.5

0.00

1

−0.04
−0.08

4a. Simultaneous−Weighted

4b. Simultaneous−Unweighted

0.00
−0.04
−0.08

0.0

0.2

0.4

0.6

0.8

0.0

0.2

0.4

0.6

0.8

γ

Figure 2.1. Binary matching variable: Comparison of bias between weighted and
naive approaches, when parameter estimates are based on logistic regression (LR),
conditional logistic regression (CLR) and the proposed procedures (Two-stage and
Simultaneous). We assume that the matched case control study is of size 100 matched
pairs.
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Estimating β [n=100 matched pairs]
1. LR

2. CLR

3. Two−stage

4. Simultaneous

Bias in estimate of β

0.1

factor(delta)
0
0.0

0.5
1

−0.1

0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8

γ

Figure 2.2. Binary matching variable: Comparison of bias between β estimates
from logistic regression (LR), conditional logistic regression (CLR) and the proposed
procedures (Two-stage and Simultaneous). We assume that the matched case control
study is of size 100 matched pairs.
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Estimating γ [n=100 matched pairs]
1. LR

2. CLR

3. Two−stage

4. Simultaneous

Bias in estimate of γ

0.0

−0.5

factor(delta)
0
0.5
1

−1.0

0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8

γ

Figure 2.3. Binary matching variable: Comparison of bias between γ estimates
from logistic regression (LR), conditional logistic regression (CLR) and the proposed
procedures (Two-stage and Simultaneous). We assume that the matched case control
study is of size 100 matched pairs.
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AUC
n=100 matched pairs
1a. LR−Weighted

1b. LR−Unweighted

2a. CLR−Weighted

2b. CLR−Unweighted

0.0
−0.1
−0.2
−0.3

0.0

Bias in estimate of AUC

−0.1
−0.2

factor(rho)

−0.3

0
3a. Two stage−Weighted

3b. Two stage−Unweighted

0.35

0.0

0.7

−0.1
−0.2
−0.3
4a. Simultaneous−Weighted

4b. Simultaneous−Unweighted

0.0
−0.1
−0.2
−0.3
0.0

0.2

0.4

0.6

0.8

0.0

0.2

0.4

0.6

0.8

γ

Figure 2.4. Continuous matching variable: Comparison of bias between weighted
and naive approaches, when parameter estimates are based on logistic regression
(LR), conditional logistic regression (CLR) and the proposed procedures (Two-stage
and Simultaneous). We assume that the matched case control study is of size 100
matched pairs.
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Estimating β [n=100 matched pairs]
1. LR
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Figure 2.5. Continuous matching variable: Comparison of bias between β estimates
from logistic regression (LR), conditional logistic regression (CLR) and the proposed
procedures (Two-stage and Simultaneous). We assume that the matched case control
study is of size 100 matched pairs.
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Estimating γ [n=100 matched pairs]
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Figure 2.6. Continuous matching variable: Comparison of bias between γ estimates
from logistic regression (LR), conditional logistic regression (CLR) and the proposed
procedures (Two-stage and Simultaneous). We assume that the matched case control
study is of size 100 matched pairs.
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CHAPTER 3
ESTIMATING THE RECEIVER OPERATING
CHARACTERISTIC CURVE IN MATCHED OR
STRATIFIED STUDIES GENERATING HIGH
DIMENSIONAL DATA

3.1

Introduction

The matched case-control study design is frequently used in biomedical research,
where the number of cases and controls are balanced within matching strata defined by
previously known confounding factors. The matching of cases to controls on potential
confounding factors has been shown to result in increased efficiency (([57, 38, 56])). In
this paper, we consider matched case control studies that generate high dimensional
datasets. For this setting, we evaluate the performance of multi-step data analysis
approach that simultaneously addresses: 1) variable selection to identify the subset
of features that are associated with the binary outcome of interest; 2) prediction or
classification based on a estimated prediction score using features selected in 1), and
3) Receiver Operative Characteristic (ROC) curve estimation associated with the
prediction rule estimated in step 2.
The matched case-control study design is commonly seen in studies characterized
by high-dimensional data (p  n). In matched case control studies, all or a subset of
cases are randomly selected from a prospective cohort. Each selected case is matched
to one or more controls on confounding factors that are previously known to be associated with the outcome of interest. This selection results in a sample of controls that
is no longer representative of the control subjects in the population. An unmatched
analysis of matched data can result in biased estimates of the biomarker-outcome as60

sociation ([56], [60]). Conditional logistic regression models are commonly employed
to estimate the magnitude and significance of the association of one or more features
with an outcome ([12], [2]). The statement of the conditional logistic regression model
includes matching stratum-specific intercepts. However, in this model, the association of a biomarker with outcome is estimated by maximization of the conditional
likelihood which eliminates the stratum-specific intercepts as nuisance parameters.
Since these models do not provide estimates of the stratum specific intercepts, they
are not appropriate for direct estimation of prediction and related statistics. In highdimensional data settings where there are significantly more features (measurements)
than subjects (p  n), the potential for overfitting during variable selection plays an
important role.
The development of methods for the analysis of high-dimensional data has been
an active area of research. A variety of variable selection approaches have been developed. See [20] for an overview of approaches such as lasso (`1 ) ([65]) and Elastic
Net ([74]). Multi step approaches to overcome overfitting have also been studied - for
example, [68] introduced an ‘screen and clean’ approach to estimate the true sparsity pattern, when there is a sparsity of true associations with outcome in datasets
with high dimensional feature measurements. None of the aforementioned approaches
account for a matched study design. We identified few papers that investigate highdimensional variable selection while considering matching. [55] developed regularization paths for conditional logistic regression, which is usually employed for the analysis
of matched case-control studies, to conduct variable selection. [63] developed a twostage variable selection method for matched case-control microarray studies, where
variables are selected using modified pair t-test in the first stage. A support vector
machine classifier is built using these selected variables in the second stage. [1] developed two variants of boosting for classification of matched-pair or correlated binary
responses with high-dimensional predictors. [8] proposed a random forest penalized
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conditional logistic regression algorithm, which adjusts for the matched case-control
design through the conditional likelihood. While these methods address variable selection in matched case control studies, they do not discuss methods for estimating a
prediction score for classification in this setting. A related approach that we incorporate in this paper is by [54], who proposed a multiple step likelihood-based method
for parameter estimation and prediction in matched case-control studies. The authors
propose methods for estimating the effects of matching factors and biomarkers in a
matched case control study by augmenting the data collected in the matched study
with information from the large prospective cohort.
In this paper we consider the dual goals of variable selection and prediction in high
dimensional datasets generated in matched case control studies. First, we evaluate
several variable selection approaches to select a subset of features in a high dimensional dataset that are associated with the outcome of interest. Second, we apply
the parameter estimation methods proposed by [54] in conjunction with an probability weighting approach to estimate the ROC curve associated with the subset of
selected features in predicting the binary outcome. We consider overfitting resulting
in the dual processes involving variable selection and prediction by considering settings in which analysis is based on a single dataset, two independent datasets and a
gold standard of three independent datasets. The paper is structured as follows: In
Section 3.2, we introduce notation, describe the setting and procedures involved in
the variable selection, estimation of prediction score and estimating the ROC curve
and associated summary index, the Area Under the Curve (AUC). In Section 3.3, we
present results from simulation studies and compare the performance of the proposed
approaches with respect to variable selection and AUC estimation. In Section 3.4,
we discuss advantages and limitations of the approaches and consider extensions to
other related settings.
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3.2

Methods

In section 3.2.1, we present the notation and define the population model. In section 3.2.2, we briefly summarize the overview of data anlaysis procedure. In section
3.2.3, we decribe the 3 variable selection approaches: 1) Lasso (`1 ) penalized conditional likelihood (clogit`1 ); 2) pair t-test with FDR adjustment (Pair t FDR); 3)
‘Screen and Clean’ procedures. In section 3.2.4, we briefly summarize the approaches
to obtain unbiased estimates of the parameters governing the population model and
derive the prediction score accordingly. In sections 3.2.5, we present a weighted estimator of the AUC that adjusts for the distortion of the prevalence of cases to controls
within strata as a result of matching.

3.2.1

Population Logistic Regression Model

Let n denote the number of subjects in the matched case control study, Y denote
a binary response variable (e.g. 1=case, 0=control) and X ∗ = (X1 , . . . , Xp∗ )T denote
a 1 × p∗ vector of features, where p∗  n. Let Z = (Z1 , . . . , Zq )T denote a 1 × q vector
of variables used in matching. We assume the following logistic regression model
at the population level to describe the association of outcome (Y) with a subset of
p  p∗ features in 1 × p vector X and matching variables Z:

logit(P r(Y = 1|X, Z) = α + β T X + γ T Z

(3.1)

where β = (β1 , . . . , βp )T and γ = (γ1 , . . . , γq )T . We assume that the primary parameters of interest are β. Variable selection strategies are employed to identify the subset
of p  p∗ features that are associated with the outcome Y in the logistic regression
model in equation 3.1. As in a typical 1 : m matched case-control study, we assume
that n subjects are enrolled such that each case is matched to m controls based on the
matching variables, Z. In this setting, we assume that a random sample of the cases
in the population are included in the study, with selection of controls according to
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the matching by variables Z. Thus, the observed data for each of the subjects in the
matched case control study include the binary outcome Y , 1 × p∗ vector of features X
and 1 × q vector of matching factors Z. To implement the matching, we assume that
the matching variables Z are used to create K matching strata. The observed data
in each matched stratum are referenced by (Ykl , Xkl , Zl ), where k = 1, ..., K, l = 1, 2,
with the index l = 1 indicating case and l = 2 indicating control.

3.2.2

Overview of Algorithm

With dual aims of variable selection and prediction, we consider a data analysis
procedure involving the following three key steps:
1. Variable Selection: Employ a variable selection procedure to identify the subset
of p  p∗ features that are associated with the outcome. We consider three
variable selection procedures, namely: (1) Lasso penalized conditional logistic
regression; (2) paired t-test while controlling the false discovery rate; and (3)
two-stage Screen and Clean procedure. Each of these approaches are described
in Section 3.2.3.
2. Estimating the prediction score: The parameters α, β, γ in the population logistic regression model in Equation (1) are estimated based on methods described
in [54]. This procedure is summarized in Section 3.2.4 and described in detail
in Chapter 2.
3. ROC curve and associated AUC estimation: By incorporating inverse probability weights to account for the non-random sampling, we estimate the ROC
curve and its associated AUC. This procedure is described in detail in Section
3.2.5.
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Overfitting: To assess the extent of overfitting when one or more of the above
three steps are carried out in the same matched dataset, we evaluated the bias in the
AUC estimation in each of the following cases:
• (A) Single matched dataset: Steps (1) - (3) are carried out in a single matched
case control dataset;
• (B) Two independent matched datasets: Steps (1) and (2) are carried in the
first and Step (3) in the second dataset.
• (C) Two independent matched datasets: Steps (1) carried out in the first and
Steps (2) and (3) in the second dataset.
• (D) Three independent datasets (Gold Standard): Each of the three steps is
carried out in an independent dataset.
See Figures 1a) and 1b) for an overview of the data analysis steps and the settings
considered with regard to the number of independent, matched case-control datasets
available for analysis.

3.2.3

Variable Selection

We consider three variable selection approaches for matched case and control
studies: 1) Lasso penalized conditional logistic model (clogit`1 ); 2) Paired t-test with
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FDR control (paired t) and 3) a two-stage ‘Screen and Clean’ procedure based on
methods proposed by [55] and [68].

Lasso penalized conditional logistic likelihood (clogit`1 ): The conditional likelihood
for a logistic regression model for analyzing data collected in matched case control
studies is given by:

L(β) =

K
Y

exp(β T Xk1 )
exp(β T Xk1 ) + exp(β T Xk2 )
k=1

(3.2)

We utilize the cyclic coordinate descent algorithm proposed by [55] to carry out
feature selection while fitting a conditional logistic regression with lasso (`1 ) penalty.
This is done by optimizing the penalized conditional logistic likelihood:

−logL(β) + λ(α

p
X

| βj |),

(3.3)

j=1

here L(β) is the conditional logistic likelihood and λ(α

Pp

j=1

| βj |) is the lasso (`1)

penalty proposed by [65]. The penalty parameter λ is estimated via n-fold cross
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validation. The regression coefficients for insignificant features are shrunk to zero
through this variable selection process. Variable selection is based on the subset of
features with non-zero values for the penalized regression coefficients.

Paired t-test with FDR control (Paired t): we conduct a paired t-test with adjustment for multiple testing through the Benjamini and Hochberg’s False Discovery Rate
(FDR) procedure ([9]). Variable selection is based on the subset of features with FDR
adjusted p-values less than 0.05.

‘Screen and Clean’ procedure (‘Screen and Clean’): We randomly split the data into
two with equal size. In Stage 1, we apply Lasso penalized conditional logistic regression model on the first half of the dataset to select features with non-zero regression
coefficients. In Stage 2, we fit univariate conditional logistic regression models for
each of the features selected in Stage 1 - features with p value less than 0.05 are
selected as true associations.

3.2.4

Parameter Estimation and Prediction Score

To estimate the parameters in the population logistic regression model in Equation
3.1, we incorporate the procedure proposed by [54]. The methods are described in
detail in Chapter 2 and summarized below.
1. Estimation offset f (Z) based on matching variables: The offset accounts for the
matching of cases to controls. To estimate the offset, we fit a logistic regression
with Y as outcome and matching factors Z as covariates in the prospective
=0|Z)
− log(m) for 1 : m
cohort data. The offset is given by: f (Z) = log P(Y
P(Y =1|Z)

matching ([54]).
2. Two-stage procedure for parameter estimation:
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(a) Estimating β: Using the data from the 1 : m matched case-control study,
we fit a conditional logistic regression model by including the biomarkers
X are predictors and obtain maximum likelihood estimates of β.
(b) Estimating α, γ: Using the data from the matched case control study, we
fit a logistic regression model where Y is the outcome and Z the vector of
predictors, while simultaneously including the offset f (Z) + β̂X estimated
in the previous step.
3. Simultaneous procedure for parameter estimation: According to this algorithm,
β, α, γ are estimated together in one model. By including the offset f (Z) ,
β, α, γ can be simultaneously estimated in a logistic regression model fit to the
matched case control study data.
4. Prediction Score: We calculate linear score for each subject in matched case
and control study to be: Ŝ = α̂ + β̂X + γ̂Z.

3.2.5

Weighted AUC Estimator

Direct estimation of the AUC in a matched case and control study can lead to
significant bias. We incorporate the inverse-probability weighting procedure described
in Chapter 2 to account for the matched sampling of controls into the study.
1. Calculation of sampling weights: Let p0k , p1k denote the proportions of controls
and cases in the k th matching stratum, where p0k + p1k = 1. In a well designed matched case control study that is nested within a prospective cohort,
the proportions of controls in each of the K strata (p01 , · · · , p0K ) should be
directly estimable. The proposed weights for each case and control within the
k th stratum are:
p0k
p0k
wk,case = 1 ; wk,control =
=
m ∗ p1k
m ∗ (1 − p0k )
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The proposed weights (wk,case , wk,control ) can be shown to rebalance the relative proportion of cases to controls to equal that in the original cohort (i.e.
p1k /p0k ).
2. Calculation of Weighted AUC: Let S = {S1 , · · · , SN } denote the linear score
based on the population logistic model (Equation (3.1)), for each subject 1, · · · , N
in the matched case control study. The weighted ROC curve is obtained from
the estimates of the true positive fraction (TPF) and false positive fraction
(FPF) from the matched case control study, adjusting for the weights, where
P

wi ∗ 1[Ŝi ≥ s]
P
i:Yi =1 wi

P

wi ∗ 1[Ŝi ≥ s]
P
.
i:Yi =0 wi

i:Yi =1

T Pd
F (s) =

i:Yi =0

F Pd
F (s) =

The associated AUC is calculated from the weighted ROC curve.

3.3

Simulation

In this section, we present simulation results to evaluate the performance of a
multi-step data analysis approach that simultaneously addresses: 1) variable selection, 2) estimation of a prediction rule, and 3) estimation of the ROC curve and its
associated AUC. Through simulations, we compare three different variable selection
strategies, consider a range of parameter values corresponding to the true population models and a range of values for the number of true biomarkers. We evaluate
the degree of overfitting when variable selection, prediction rule and associated AUC
estimation are carried out in one, two and three independent matched case-control
studies.
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3.3.1

Data Simulation

Data Generation: We first simulate a large dataset representing a prospective cohort in which the population logistic model in Equation (3.1) holds. For all subjects in
the population, we simulate a binary matching variable Z, where Z ∼ Bernoulli(0.5).
For each subject in the cohort, we simulate 10,000 i .i .d . {X1 · · · , X10000 }, where
Xi |Z=0 ∼ N(0, 1) and Xi |Z=1 ∼ N(δ, 1) - here, δ is the predefined parameter quantifying the shift in mean levels of each feature Xp through the matching factor Z.
Within the 10,000 features Xp , we assume that certain number of true biomarkers X
are associated with the binary outcome Y with a corresponding nonzero coefficient
β in the logistic regression model in Equation (3.1). Assuming fixed values of the regression coefficients α, β, γ, we simulate the outcome Y of each subject in the cohort
according to a Bernoulli random variable with probability of p = Pr(Y = 1|X, Z)
given by Equation (3.1). From the simulated population cohort, a matched casecontrol study of size n pairs is drawn as follows: A random sample of cases (Y = 1)
of size n is selected. For each selected case, a matching control (Y = 0) is selected,
such that the case and its matched control have the same value of Z. We generate
three independent training, testing and validation matched case-control datasets.

Parameter Values: We consider a range of settings corresponding to each of the
following parameters:
• Varying the strength of association between the outcome Y and matching variable Z by varying the value of γ = {0, 0.25, 0.5}.
• We vary strength of the association of the matching variable Z on biomarker
levels X by varying the value of δ = {0, 1}.
• We vary the number of true biomarkers to equal 2, 5 and 10. For each of these
numbers of true biomarkers, we set the regression coefficients β as noted below:
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1. Number of true biomarkers = 2, β1 = β2 = 0.5 and βj = 0 for all the other
covariates.
2. Number of true biomarkers = 5, β1 = β2 = β3 = 0.5, β4 = β5 = −0.5 and
βj = 0 for all the other covariates.
3. Number of true biomarkers = 10, βj = 0.5 for j = 0, . . . , 5 and βj = -0.5
for j = 6, . . . , 10 and βj = 0 for all the other covariates.
We set the number of matched pairs of cases and controls to n = 100 pairs for the
training, testing and validations sets. In all scenarios, we adjust the parameter α so
that the population incidence rate is approximately 10%.

3.3.2

Simulation Strategy

3.3.2.1

Evaluating overfitting

We evaluate the degree of overfitting in the AUC estimation process by considering
the following scenarios with regard to the number of independent, matched datasets
available for analysis:
• Scenario 1: We select variables, estimate the prediction score and calculate AUC
estimates all in one matched case-control data.
• Scenario 2: We select variables and estimate the prediction score in the first
matched case-control dataset and calculate AUC estimates in the second independent matched case-control dataset.
• Scenario 3: We select variables in the first matched case-control dataset, estimate the prediction score and calculate AUC estimates in the second, independent matched case-control dataset.
• Scenario 4: We select variables, estimate the prediction score and calculate
AUC estimates in three independent, matched case-control datasets. The AUC

71

estimate derived in this setting serves as the benchmark or gold standard for
evaluating the degree of overfitting.

3.3.2.2

Variable Selection and Estimating Prediction Score

We consider three different approaches for variable selection as described in Section 2.3.
• clogit`1 : We fit the Lasso penalized conditional logistic regression model in
the matched case-control data to select variables. Since Lasso tends to select
more variables, we limit the number of selected variables to be a maximum
of 15, ranking the variables according to the absolute values of the penalized
regression parameter estimates.
• Pair t: We use the univariate pair t-test with Benjamini and Hochberg’s FDRcontrolling procedure in the matched case-control dataset to select variables.
Variables with FDR adjusted p-value < 0.05 are selected as true associations.
• Screen and Clean: We randomly split the matched case-control dataset into
two halves. We fit the Lasso penalized conditional logistic regression model in
the first half and select all variables with non-zero estimates of the penalized
regression coefficients. In the second half of the dataset, we fit univariate conditional logistic regression models for each of the selected variables. Variables
with p-value < 0.05 are selected as true associations.
Average AUC estimates based on 100 simulations are reported. The probability of
selecting true biomarkers (p1 ) and selection non-markers (p2 ) are reported for each
variable selection approach.
Based on 100 simulations, average AUC’s are reported. We apply the approaches
described in section 2.4 to obtain estimates of regression parameters β̂, α̂ and γ̂. By
calculating α̂ + β̂X + γ̂Z as the prediction score and estimated inverse probability
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weights from the prospective cohort dataset, we obtain estimates of the AUC using
both the Multi-Step and Simultaneous approaches.

3.3.3

Simulation Results

Tables 3.1-3.9 present the estimates of AUC, the probability of true biomarkers
being selected (p1 ) and the probability of non-marker being selected (p2 ) , assuming
the size of matched case-control studies is n = 100 pairs and number of covariates is
p = 10, 000 . Averaged AUC estimates based on 100 simulations are presented for each
of the four scenarios described in Section 3.4.2.1 for different parameter settings (γ, δ)
. See Tables 3.1-3.3 for results corresponding to variable selection by the univariate
paired t-test and with Benjamini and Hochberg’s FDR-controlling procedure (pair
t-test); Tables 3.4-3.6 for results corresponding to variable selection by the two-stage
‘Screen and Clean’ approach; and Tables 3.7-3.9 for results corresponding to variable
selection by the single stage Lasso (clogit`1 ). Figures 1-9 show the comparison of
AUC estimates under different parameter settings for each of the four scenarios in
Section 3.4.2.1, using each of the three variable selection approaches being compared.

Variable Selection: When comparing variable selection approaches, clogit`1 has
the largest true positive rate or sensitivity but with also a corresponding increase in
false discovery rate. The lowest levels of false discovery rate was observed with the
paired t-test with FDR adjustment. Notably, the paired t-test performed better than
the ‘Screen and Clean’ approach with regard to sensitivity (or true positive rate). For
example, consider the setting where number of true biomarkers is 2, β1 = β2 = 0.5,
γ=0.5 and δ=1, the true positive rates are 0.940, 0.630 and 0.425 for clogit`1, Pair
t-test and ‘Screen and Clean’, respectively. For the same setting, the false positive
rates were 0.00121, 0.00001 and 0.00021 for clogit`, Pair t-test and ‘Screen and Clean’,
respectively. This trend was observed when the number of biomarkers were 5 or 10
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among 10,000 features measured per subject.

Overfitting: For each setting involving variable selection and set of parameters,
we compare weighted AUC estimate obtained when there are one, two or three independent matched datasets available for analysis (See Section 3.3.2.1). We compare
the AUC’s estimated in Scenarios 1-3 to the gold standard setting of Scenario 4 (three
independent datasets). Across all settings considered, the level of overfitting is the
highest when there is only 1 matched dataset available for analysis. When δ = 1,
the level of overfitting in the 1-dataset (Scenario 1) analysis increases with increasing
values of γ. This trend is not observed when δ = 0. The clogit`1 variable selection
approach also has an associated large level of overfitting in the 1-dataset (Scenario 1)
setting when compared to other variable selection approaches (See Figures 3.7 - 3.9).
This is expected as this approach also has the highest false positive rate.
The magnitude of overfitting in the two scenarios (2 and 3) involving two independent matched datasets appear minimal when variable selection is based on the
paired t-test or the ‘Screen and Clean’ procedure. The distribution of AUC in Scenario 2 appears most similar to that in the gold standard setting of three independent
datasets (Scenario 4). However, when the prediction score includes a large number
of false positives due to variable selection by clogit`1, Scenario 2 results in AUC
estimates that are biased downward when compared to Scenario 4. In Scenario 2,
variable selection and estimation of parameters in the prediction score are estimated
in one dataset and the AUC is estimated in a second independent dataset. Thus, in
this setting, inclusion of a large number of false positives in the prediction score with
correspondingly large non-zero coefficient estimates from the first dataset results in
inferior performance in the second independent dataset.
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3.4

Discussion

In settings of high dimensional datasets generated in matched case-control studies,
we evaluate a simultaneous data analysis procedure that includes steps for variable
selection, estimation of a prediction rule and its corresponding summary index such
as the AUC for quantifying the strength of prediction. Through simulations, effects of
several factors were manipulated including: (1) the strength of association of matching
factors with outcome; (2) the correlation between matching factors and biomarkers;
and (3) number of true biomarkers. We compare three variable selection approaches
including: (1) Lasso penalized conditional logistic regression model (clogit`1); (2) Pair
t-test with FDR control(Pair t); and the (3) ‘Screen and Clean’ procedure (’Screen
and Clean’).
The simulations showed that the penalized Lasso conditional logistic regression
approach (clogit`1) resulted in the highest true positive rate but this approach also
suffers from a high false positive rate. This approach also had the highest level of
overfitting in AUC estimation when all steps of analysis were carried out in a single
matched case control study dataset. The paired t with FDR control embraces the
advantage of low false positive rate with a moderately high true positive rate. However, this approach can further suffer when there are complex correlation structures
of covariates. Interestingly, in this setting where the features were simulated as independent random variables, the ‘Screen and Clean’ approach did not do as well as the
paired t with FDR control, considering both true positive and false positive rates.
We expect that this trend will differ in settings where the features are characterized
by complex correlation structures.
We evaluated the extent of overfitting in settings of one, two and three independent matched case-control datasets. A large magnitude of overfitting is observed
when the multiple-step analysis is carried out on one matched case-control study when
compared to three independent dataset setting, considered to be the gold standard.
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When the analysis is carried out in two independent matched datasets, the overfitting
is better controlled.
Further research into settings involving complex correlations between features
would be desirable.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.6852

0.6917

0.6537

0.6619 0.6607 0.635 0.00002

Simultaneous/Weighted

0

0

0.6852

0.6920

0.6543

0.6620 0.6687 0.635 0.00002

0.25

0

0.6891

0.6825 0.6535 0.6583

0.6533

0.565 0.00001

Simultaneous/Weighted 0.25

0

0.6891

0.6829 0.6542 0.6584

0.6534

0.565 0.00001

MultiStage/Weighted

0.5

0

0.6983 0.6925

0.6668 0.6703

0.6722

0.615 0.00001

Simultaneous/Weighted

0.5

0

0.6983 0.6928

0.6669 0.6705

0.6725

0.615 0.00001

MultiStage/Weighted

0

1

0.7227

0.7244

0.7016

0.7074 0.7012 0.565 0.00001

Simultaneous/Weighted

0

1

0.7227

0.7247

0.7017

0.7076 0.7014 0.565 0.00001

0.25

1

0.7375

0.7410 0.7168 0.7237

0.7217

0.610 0.00002

Simultaneous/Weighted 0.25

1

0.7375

0.7413 0.7175 0.7240

0.7220

0.610 0.00002

MultiStage/Weighted

0.5

1

0.7545 0.7594

0.7305 0.7412

0.7394

0.630 0.00001

Simultaneous/Weighted

0.5

1

0.7545 0.7597

0.7313 0.7416

0.7393

0.630 0.00001

MultiStage/Weighted

MultiStage/Weighted

Table 3.1: Pair t-test: Comparison of AUC estimates using weighted Multi-stage and
Simultaneous estimators. AUC estimates are compared when one (Scenario 1), two
(Scenario 2 and Scenario 3) and three (Scenario 4) independent matched case-control
studies are available. The probability of true biomarkers being selected (p1 ) and
non-markers being selecting (p1 ) are reported. Results are based on 100 simulations,
where the true number of biomarkers = 2.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.7701

0.7305

0.6872

0.6940 0.6894 0.504 0.00001

Simultaneous/Weighted

0

0

0.7701

0.7315

0.6878

0.6946 0.6899 0.504 0.00001

0.25

0

0.7703

0.7306 0.6865 0.6957

0.6894

0.464 0.00002

Simultaneous/Weighted 0.25

0

0.7703

0.7312 0.6870 0.6962

0.6898

0.464 0.00002

MultiStage/Weighted

0.5

0

0.7758 0.7292

0.6864 0.6951

0.6925

0.476 0.00002

Simultaneous/Weighted

0.5

0

0.7758 0.7299

0.6872 0.6956

0.6930

0.476 0.00002

MultiStage/Weighted

0

1

0.7755

0.7435

0.6944

0.7056 0.6998 0.502 0.00003

Simultaneous/Weighted

0

1

0.7755

0.7440

0.6950

0.7061 0.7006 0.502 0.00003

0.25

1

0.7814

0.7440 0.7031 0.7107

0.7060

0.488 0.00002

Simultaneous/Weighted 0.25

1

0.7814

0.7446 0.7035 0.7110

0.7064

0.488 0.00002

MultiStage/Weighted

0.5

1

0.7887 0.7521

0.7165 0.7244

0.7127

0.476 0.00002

Simultaneous/Weighted

0.5

1

0.7887 0.7258

0.7172 0.7250

0.7133

0.476 0.00002

MultiStage/Weighted

MultiStage/Weighted

Table 3.2: Pair t-test: Comparison of AUC estimates using weighted Multi-stage and
Simultaneous estimators. AUC estimates are compared when one (Scenario 1), two
(Scenario 2 and Scenario 3) and three (Scenario 4) independent matched case-control
studies are available. The probability of true biomarkers being selected (p1 ) and
non-markers being selecting (p1 ) are reported. Results are based on 100 simulations,
where the true number of biomarkers = 5.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.8379

0.7570

0.6977

0.7072 0.6980 0.374 0.00002

Simultaneous/Weighted

0

0

0.8379

0.7580

0.6982

0.7081 0.6980 0.374 0.00002

0.25

0

0.8403

0.7551 0.7049 0.7134

0.6948

0.362 0.00002

Simultaneous/Weighted 0.25

0

0.8403

0.7561 0.7058 0.7143

0.6954

0.362 0.00002

MultiStage/Weighted

0.5

0

0.8392 0.7481

0.6939 0.7040

0.6947

0.334 0.00001

Simultaneous/Weighted

0.5

0

0.8392 0.7491

0.6951 0.7048

0.6948

0.334 0.00001

MultiStage/Weighted

0

1

0.8454

0.7579

0.7021

0.7142 0.7042 0.318 0.00003

Simultaneous/Weighted

0

1

0.8454

0.7589

0.7042

0.7148 0.7045 0.318 0.00003

0.25

1

0.8495

0.7782 0.7202 0.7335

0.7260

0.342 0.00003

Simultaneous/Weighted 0.25

1

0.8495

0.7792 0.7209 0.7342

0.7265

0.342 0.00003

MultiStage/Weighted

0.5

1

0.8548 0.7708

0.7246 0.7347

0.7256

0.302 0.00002

Simultaneous/Weighted

0.5

1

0.8548 0.7714

0.7255 0.7351

0.7262

0.302 0.00002

MultiStage/Weighted

MultiStage/Weighted

Table 3.3: Pair t-test: Comparison of AUC estimates using weighted Multi-stage and
Simultaneous estimators. AUC estimates are compared when one (Scenario 1), two
(Scenario 2 and Scenario 3) and three (Scenario 4) independent matched case-control
studies are available. The probability of true biomarkers being selected (p1 ) and
non-markers being selecting (p1 ) are reported. Results are based on 100 simulations,
where the true number of biomarkers = 10.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.6852

0.6733

0.6058

0.6287 0.6131 0.505 0.00017

Simultaneous/Weighted

0

0

0.6852

0.6739

0.6053

0.6291 0.6137 0.505 0.00017

0.25

0

0.6891

0.6715 0.5990 0.6272

0.6114

0.440 0.00020

Simultaneous/Weighted 0.25

0

0.6891

0.6719 0.5987 0.6275

0.6112

0.440 0.00020

MultiStage/Weighted

0.5

0

0.6983 0.6819

0.6226 0.6484

0.6299

0.470 0.00018

Simultaneous/Weighted

0.5

0

0.6983 0.6823

0.6227 0.6487

0.6300

0.470 0.00018

MultiStage/Weighted

0

1

0.7227

0.7189

0.6563

0.6834 0.6698 0.485 0.00027

Simultaneous/Weighted

0

1

0.7227

0.7195

0.6570

0.6840 0.6707 0.485 0.00027

0.25

1

0.7375

0.7291 0.6746 0.6089

0.6858

0.445 0.00025

Simultaneous/Weighted 0.25

1

0.7375

0.7299 0.6744 0.6993

0.6865

0.445 0.00025

MultiStage/Weighted

0.5

1

0.7545 0.7442

0.6978 0.7173

0.7039

0.425 0.00021

Simultaneous/Weighted

0.5

1

0.7545 0.7446

0.6978 0.7176

0.7045

0.425 0.00021

MultiStage/Weighted

MultiStage/Weighted

Table 3.4: Screen and Clean: Comparison of AUC estimates using weighted Multistage and Simultaneous estimators. AUC estimates are compared when one (Scenario
1), two (Scenario 2 and Scenario 3) and three (Scenario 4) independent matched
case-control studies are available. The probability of true biomarkers being selected
(p1 ) and non-markers being selecting (p1 ) are reported. Results are based on 100
simulations, where the true number of biomarkers = 2.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.7701

0.7100

0.6497

0.6713 0.6536 0.408 0.00017

Simultaneous/Weighted

0

0

0.7701

0.7107

0.6501

0.6721 0.6544 0.408 0.00017

0.25

0

0.7703

0.7080 0.6466 0.6662

0.6510

0.378 0.00016

Simultaneous/Weighted 0.25

0

0.7703

0.7089 0.6479 0.6667

0.6517

0.378 0.00016

MultiStage/Weighted

0.5

0

0.7758 0.7171

0.6611 0.6808

0.6722

0.404 0.00013

Simultaneous/Weighted

0.5

0

0.7758 0.7180

0.6626 0.6816

0.6731

0.404 0.00013

MultiStage/Weighted

0

1

0.7755

0.7213

0.6625

0.6845 0.6638 0.394 0.00020

Simultaneous/Weighted

0

1

0.7755

0.7221

0.6629

0.6853 0.6640 0.394 0.00020

0.25

1

0.7814

0.7269 0.6735 0.6949

0.6805

0.412 0.00015

Simultaneous/Weighted 0.25

1

0.7814

0.7278 0.6736 0.6957

0.6809

0.412 0.00015

MultiStage/Weighted

0.5

1

0.7887 0.7393

0.6801 0.7019

0.6926

0.38

0.00016

Simultaneous/Weighted

0.5

1

0.7887 0.7400

0.6810 0.7024

0.6928

0.38

0.00016

MultiStage/Weighted

MultiStage/Weighted

Table 3.5: Screen and Clean: Comparison of AUC estimates using weighted Multistage and Simultaneous estimators. AUC estimates are compared when one (Scenario
1), two (Scenario 2 and Scenario 3) and three (Scenario 4) independent matched
case-control studies are available. The probability of true biomarkers being selected
(p1 ) and non-markers being selecting (p1 ) are reported. Results are based on 100
simulations, where the true number of biomarkers = 5.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.8379

0.7238

0.6516

0.6699 0.6585 0.259 0.00017

Simultaneous/Weighted

0

0

0.8379

0.7248

0.6527

0.6706 0.6590 0.259 0.00017

0.25

0

0.8403

0.7240 0.6452 0.6677

0.6627

0.252 0.00014

Simultaneous/Weighted 0.25

0

0.8403

0.7250 0.6462 0.6685

0.6631

0.252 0.00014

MultiStage/Weighted

0.5

0

0.8392 0.7096

0.6532 0.6693

0.6556

0.227 0.00012

Simultaneous/Weighted

0.5

0

0.8392 0.7105

0.6539 0.6701

0.6559

0.227 0.00012

MultiStage/Weighted

0

1

0.8454

0.7361

0.6838

0.6999 0.6896 0.246 0.00012

Simultaneous/Weighted

0

1

0.8454

0.7371

0.6842

0.7007 0.6898 0.246 0.00012

0.25

1

0.8495

0.7421 0.6901 0.7085

0.6923

0.222 0.00016

Simultaneous/Weighted 0.25

1

0.8495

0.7430 0.6908 0.7091

0.6927

0.222 0.00016

MultiStage/Weighted

0.5

1

0.8548 0.7588

0.7022 0.7228

0.7118

0.237 0.00015

Simultaneous/Weighted

0.5

1

0.8548 0.7596

0.7036 0.7234

0.7129

0.237 0.00015

MultiStage/Weighted

MultiStage/Weighted

Table 3.6: Screen and Clean: Comparison of AUC estimates using weighted Multistage and Simultaneous estimators. AUC estimates are compared when one (Scenario
1), two (Scenario 2 and Scenario 3) and three (Scenario 4) independent matched
case-control studies are available. The probability of true biomarkers being selected
(p1 ) and non-markers being selecting (p1 ) are reported. Results are based on 100
simulations, where the true number of biomarkers = 10.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.6852

0.8442

0.5877

0.7015 0.6548 0.930 0.00117

Simultaneous/Weighted

0

0

0.6852

0.8497

0.5943

0.7065 0.6599 0.930 0.00117

0.25

0

0.6891

0.8349 0.5938 0.6994

0.6570

0.920 0.00112

Simultaneous/Weighted 0.25

0

0.6891

0.8398 0.5988 0.7044

0.6621

0.920 0.00112

MultiStage/Weighted

0.5

0

0.6983 0.8360

0.5960 0.7045

0.6633

0.890 0.00112

Simultaneous/Weighted

0.5

0

0.6983 0.8410

0.6008 0.7096

0.6684

0.890 0.00112

MultiStage/Weighted

0

1

0.7227

0.8447

0.6178

0.7319 0.6935 0.920 0.00110

Simultaneous/Weighted

0

1

0.7227

0.8508

0.6239

0.7381 0.6997 0.920 0.00110

0.25

1

0.7375

0.8521 0.6289 0.7446

0.7122

0.900 0.00111

Simultaneous/Weighted 0.25

1

0.7375

0.8583 0.6351 0.7506

0.7182

0.900 0.00111

MultiStage/Weighted

0.5

1

0.7545 0.8700

0.6383 0.7667

0.7351

0.940 0.00121

Simultaneous/Weighted

0.5

1

0.7545 0.8758

0.6441 0.7727

0.7410

0.940 0.00121

MultiStage/Weighted

MultiStage/Weighted

Table 3.7: clogit`1 : Comparison of AUC estimates using weighted Multi-stage and
Simultaneous estimators. AUC estimates are compared when one (Scenario 1), two
(Scenario 2 and Scenario 3) and three (Scenario 4) independent matched case-control
studies are available. The probability of true biomarkers being selected (p1 ) and
non-markers being selecting (p1 ) are reported. Results are based on 100 simulations,
where the true number of biomarkers = 2.
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Method

γ

δ

ˆ
AUC

AUC
1

2

p1
3

p2

4

MultiStage/Weighted

0

0

0.7701

0.8693

0.6560

0.7613 0.7273 0.862 0.00106

Simultaneous/Weighted

0

0

0.7701

0.8787

0.6670

0.7667 0.7326 0.862 0.00106

0.25

0

0.7703

0.8679 0.6501 0.7565

0.7180

0.818 0.00106

Simultaneous/Weighted 0.25

0

0.7703

0.8766 0.6585 0.7611

0.7233

0.818 0.00106

MultiStage/Weighted

0.5

0

0.7758 0.8686

0.6577 0.7639

0.7294

0.852 0.00104

Simultaneous/Weighted

0.5

0

0.7758 0.8773

0.6660 0.7685

0.7346

0.852 0.00104

MultiStage/Weighted

0

1

0.7755

0.8706

0.6601

0.7679 0.7311 0.844 0.00106

Simultaneous/Weighted

0

1

0.7755

0.8828

0.6672

0.7727 0.7404 0.844 0.00106

0.25

1

0.7814

0.8736 0.6580 0.7680

0.7352

0.824 0.00106

Simultaneous/Weighted 0.25

1

0.7814

0.8828 0.6667 0.7733

0.7404

0.824 0.00106

MultiStage/Weighted

0.5

1

0.7887 0.8773

0.6671 0.7822

0.7462

0.854 0.00106

Simultaneous/Weighted

0.5

1

0.7887 0.8856

0.6756 0.7870

0.7511

0.854 0.00106

MultiStage/Weighted

MultiStage/Weighted

Table 3.8: clogit`1 : Comparison of AUC estimates using weighted Multi-stage and
Simultaneous estimators. AUC estimates are compared when one (Scenario 1), two
(Scenario 2 and Scenario 3) and three (Scenario 4) independent matched case-control
studies are available. The probability of true biomarkers being selected (p1 ) and
non-markers being selecting (p1 ) are reported. Results are based on 100 simulations,
where the true number of biomarkers = 5.
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Method

γ

δ

ˆ
AUC

AUC
1

2

3

p1

p2

4

MultiStage/Weighted

0

0

0.8379 0.8792

0.6991 0.7854 0.7596

0.675

0.00121

Simultaneous/Weighted

0

0

0.8379 0.8892

0.7117 0.7920 0.7663

0.675

0.00121

MultiStage/Weighted

0.25

0

0.8403

0.8816 0.7027

0.7938 0.7608

0.688

0.00121

Simultaneous/Weighted

0.25

0

0.8403

0.8919 0.7165

0.8003 0.7656

0.688

0.00121

MultiStage/Weighted

0.5

0

0.8392

0.8802 0.7077

0.7986

0.7668 0.703

0.00117

Simultaneous/Weighted

0.5

0

0.8392

0.8905 0.7222

0.8040

0.7720 0.703

0.00117

MultiStage/Weighted

0

1

0.8454 0.8761

0.7123 0.7968 0.7625

0.665

0.00122

Simultaneous/Weighted

0

1

0.8454 0.8828

0.7208 0.8013 0.7738

0.665

0.00122

MultiStage/Weighted

0.25

1

0.8495

0.8856 0.7178

0.8061 0.7723

0.688

0.00112

Simultaneous/Weighted

0.25

1

0.8495

0.8918 0.7249

0.8155 0.7801

0.688

0.00112

MultiStage/Weighted

0.5

1

0.8548

0.8892 0.7280

0.8296

0.7781 0.693

0.00121

1

0.8548 0.8912

0.7359 0.8322 0.7838 0.693

0.00121

Simultaneous/Weighted t 0.5

Table 3.9: clogit`1 : Comparison of AUC estimates using weighted Multi-stage and
Simultaneous estimators. AUC estimates are compared when one (Scenario 1), two
(Scenario 2 and Scenario 3) and three (Scenario 4) independent matched case-control
studies are available. The probability of true biomarkers being selected (p1 ) and
non-markers being selecting (p1 ) are reported. Results are based on 100 simulations,
where the true number of biomarkers = 10.
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Figure 3.1. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario
2, Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the paired t-test with FDR control. The number of biomarkers is assumed to equal to 2. True AUC is presented by dotted-dash
line.
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Figure 3.2. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario
2, Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the paired t-test with FDR control. The number of biomarkers is assumed to equal to 5. True AUC is presented by dotted-dash
line.
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Figure 3.3. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario
2, Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the paired t-test with FDR control. The number of biomarkers is assumed to equal to 10. True AUC is presented by dotted-dash
line.
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Figure 3.4. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario
2, Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the ’Screen and Clean’ approach. The number of biomarkers is assumed to equal to 2. True AUC is presented by dotted-dash
line.
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Figure 3.5. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario
2, Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the ’Screen and Clean’ approach. The number of biomarkers is assumed to equal to 5. True AUC is presented by dotted-dash
line.
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Figure 3.6. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario
2, Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the ’Screen and Clean’ approach. The number of biomarkers is assumed to equal to 10. True AUC is presented by dotted-dash
line.
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Figure 3.7. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario 2,
Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the clogit`1 approach. The number of
biomarkers is assumed to equal to 2. True AUC is presented by dotted-dash line.
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Figure 3.8. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario 2,
Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the clogit`1 approach. The number of
biomarkers is assumed to equal to 5. True AUC is presented by dotted-dash line.
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Figure 3.9. Comparing the distribution of AUC estimates from the weighted MultiStage (M) and Simultaneous (S) approaches, when one (Scenario 1), two (Scenario 2,
Scenario 3) and three (Scenario 4) independent, matched case-control studies are
available. Variable selection is based on the clogit`1 approach. The number of
biomarkers is assumed to equal to 10. True AUC is presented by dotted-dash line.
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APPENDIX A
SUPPLEMENTARY MATERIALS FOR CHAPTER 1

A.0.1

Effects of error in self-reported outcomes on variable selection by
Random Survival Forests (RSF)

We illustrate the degradation in the variable selection performance of the original
RSF algorithm, with increasing error in the self-reported outcomes.
Each simulated dataset included N = 100 subjects and P = 100 covariates, of
which the first five (Z1 , · · · , Z5 ) were assumed to be true biomarkers. We assumed that
the duration of follow-up was 4 years and that there were annual visits at which selfreported outcomes were collected. We assumed that there were no missed visits. Each
covariate was simulated according to an independent standard normal distribution.
We assumed that the true time to event followed an exponential distribution and
that the set of five biomarkers influenced the outcome through a proportional hazards
model. Let λ0 denote the hazard corresponding to the reference group (corresponding
to Z1 = · · · = Z5 = 0). Under the proportional hazards model, the hazard for a
subject with arbitrary values of the covariates Z1 , · · · , Z5 is given by:

λZ1 ,Z2 ,Z3 ,Z4 ,Z5 = λ0 eβ1 Z1 +β2 Z2 +β3 Z3 +β4 Z4 +β5 Z5

We set the values of λ0 to correspond to values of cumulative incidence for the reference group of 0.15, 0.25 and 0.5, respectively. The values of β1 , · · · , β5 were set to 2.
For each subject i, observed values of the binary, self-reported outcomes at visits at
years 1-4 (Ri1 , · · · , Ri4 ) were simulated by assuming specific values for the sensitivity
and specificity of self-reports.
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For example, assume that the simulated time-to-event for subject i is Xi = 2.5
years, the sensitivity and specificity of self-reported outcomes are ϕ1 = 0.9 and
ϕ0 = 0.7, respectively. Then, the self-reported outcomes at visits 1-4 are simulated
according to P(Ri1 = 1 | Xi = 2.5, ti1 = 1) = P(Ri2 = 1 | Xi = 2.5, ti2 = 2) = 1 − ϕ0
and P(Ri3 = 1 | Xi = 2.5, ti3 = 3) = P(Ri4 = 1 | Xi = 2.5, ti4 = 4) = ϕ1 .
We fit the RSF algorithm to each simulated dataset, by setting the number of
trees to 1000. The variables ranking among the top 5% were considered as “discovered biomarkers”. Averaging over 100 simulations for each setting, we estimated the
proportion of datasets in which each of the true five biomarkers (Z1 = · · · = Z5 ) was
“discovered”.
Panels (a) - (b) of Figure 3 of the Supplement present the proportion of times
that true biomarkers were ranked among the top 5 by RSF as a function of sensitivity
or specificity. We consider different parameter settings corresponding to (sensitivity,
specificity) of the self-reported outcome and cumulative incidence (in the reference
group). The results show that the reduction in specificity has a deleterious effect on
variable selection, when sensitivity is assumed to be perfect (Figure 3 of Supplement,
Panel (a)). On the other hand, when specificity is fixed at 1, reduction in sensitivity
has a modest effect on variable selection (Figure 3 of Supplement, Panel (b)). When
sensitivity, specificity and cumulative incidence were set to 0.61, 0.995 and 0.15 respectively (characteristics of diabetes self-reports in the WHI), we observed that the
true five biomarkers were discovered among the top five variables on average 66% of
the time - in comparison, when self-reports are perfect, the true five biomarkers were
discovered among the top five variables on average 80% of the time.

A.0.2

Cardiovascular Disease Omics Study

The distribution of the Pearson’s correlation between pairs of covariates is shown
in Figure 4. The data are restricted to 100 selected covariates and correlations are
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calculated following standardization of each covariate by subtracting its mean and
dividing by its standard deviation. The pairwise Pearson’s correlations range from
-0.54 to 0.99.
Figure 5 shows the marginal distributions of the standardized values of each of
the 5 selected biomarkers from the cardiovascular disease omics study.

A.0.3

Baseline characteristics of the subjects in the WHI Clinical Trials
and Observational Study SHARe
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Figure A.1. Effects of error in self-reported outcomes on Random Survival Forests:
Proportion of datasets in which the true biomarkers ranked among the top five by
Random Survival Forests, under different parameter settings with respect to sensitivity (ϕ1 ), specificity (ϕ0 ) and cumulative incidence in the reference group during
study period. Data were simulated assuming no missed visits.

98

250

200

Frequency

150

100

50

0
−1.0

−0.5

0.0

0.5

1.0

Between Covariate Correlation

Figure A.2. Cardiovascular Disease Omics Study: Distribution of Pearson’s correlation between pairs of 100 selected covariates covariates.
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Figure A.3. Cardiovascular Disease Omics Study: Marginal distributions of the
standardized values of each of the 5 selected biomarkers.
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Continuous Variables

Mean(SD)

Age(years)

60.65(6.768)

Dietary Energy Intake

1121.56(932.210)

Minutes of recreational physical activity per week

153.41(171.475)

Body Mass Index

30.02(6.043)

Categorical Variables

N (%)

Smoking Status
Never smoked

5372 (54%)

Past smoker

3567 (36%)

Current smoker

934 (10 %)

Alcohol Intake
Non-drinker

1597 (16%)

Past drinker

2693 (27%)

<1 drink per month

1375 (14%)

<1 drink per week

2088 (21%)

1 to <7 drink per week

1647 (17%)

7+ drink per week

473 (5%)

Hormone Therapy Use
Never use hormones

4310 (43 %)

Past hormone user

2340 (24%)

current hormone user

3223 (33%)

Family History of Diabetes
No

4838 (49%)

Yes

4198 (43 %)

Don’t know

837 (8 %)

Education
<8 grade

1244 (13%)

High school

1404 (14%)

College

3743 (38%)

Post-graduation

3482 (35%)

Table A.1: Baseline characteristics of the subjects in the WHI Clinical Trials and
Observational Study SHARe (n = 9, 873).
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APPENDIX B
TUTORIAL FOR USING R PACKAGE ICRSF

The R package icRSF can be downloaded from CRAN. Here, we will present a
tutorial on how to use the functions included in the package and carry out the analysis
described in this paper. We use a simulated dataset of N subjects and P covariates
as example.
library(icRSF)
data(Xmat)
We simulated a dataset with N = 1000 subjects and P = 300 covariates - we
assume that 5 covariates are true biomarkers with the effect size of 0.7. The function
simout() is used to simulate the dataset:
sim <- simout(Xmat=Xmat, testtimes=1:4, sensitivity=1, specificity=1,
noevent=0.7, betas=c(rep(0.7, 5), rep(0, ncol(Xmat)-5)),
design="NMISS")
The simout() function requires the following inputs:
1. Xmat is a 300×1000 covariate matrix that we simulated independently from
binomial distribution with p=0.4.
2. testtimes is the vector of times at which self-reported outcomes are collected for
all subjects.
3. sensitivity denotes the sensitivity of the self-report
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4. specificity denotes the specificity of the self-report
5. noevent denotes the probability of remaining event free by study end (or the
complement of cumulative incidence)
6. betas denotes the vector of regression coefficients associated with the set of
biomarkers in the Cox PH model
7. design denotes whether tests are missing after first positive result. ‘NMISS’
denotes no missing test after first positive and ’NTFP’ denotes all tests are
missing after first positive
The function returns a data frame simdata, which is a simulated longitudinal
form of data result observed with error with dimension of 2400×3, where first column
are the subject IDs, second column are the test times and the third column are the
testing results.
The forest with multiple trees is constructed using icrsf() function:
data(simdata)
data(Xmat)
vimp <- icrsf(data=simdata, subject=ID, testtimes=time, result=result,
sensitivity=1, specificity=1, Xmat=Xmat, root.size=10,
ntree=2, p=sqrt(ncol(Xmat)), node=2)
Let N ∗∗ denote the number of visits summed over all subjects in the study. Let
N, P denote the number of subjects and number of variables in the dataset. The
modified random survival forest algorithm is implemented using the icrsf() function
that requires the following inputs:
1. simdata: name of the data frame that includes the variables subject, testtimes,
result
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2. subject: vector of subject IDs of length N ∗∗ × 1.
3. testtimes: vector of visit or test times of length N ∗∗ × 1.
4. result: vector of binary diagnostic test results (0 = negative for event of interest;
1 = positive for event of interest) of length N ∗∗ × 1.
5. Xmat: a N × P matrix of covariates.
6. root.size: minimum number of subjects in a terminal node.
7. ntree: number of survival trees.
8. p: number of covariate selected at each node to split the tree.
9. node: For parallel computation, specify the number of nodes.
The output of the function call to icrsf() is a vector of length p × 1 of variable
importance, where large values of the metric indicate a higher level of importance.
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APPENDIX C
ADDITIONAL SIMULATIONS RESULTS FOR CHAPTER 2

We present detailed results from simulations, considering the cases when the
matching variable Z is binary. We consider sample sizes of n = 250 matched case
control pairs.
Appendix Tables C.1- C.3 present the estimates of AUC, β, γ and associated standard error (SE) for each parameter setting. Web Figures C.1- C.3 present estimates
of bias (SE) associated with estimates of β, γ, based on logistic regression (LR), conditional logistic regression (CLR) and the proposed methods parameter estimation
(Section 2.2).
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Model

β

γ

δ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.75
0.75

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

0.5085
0.5045
0.5045
0.5085
0.5018
0.4995
0.4995
0.5018
0.5034
0.5071
0.5071
0.5034
0.4880
0.4944
0.4944
0.4880

0.0117
0
-0.0018
-0.0014
0.0099
0
0.2407
0.2406
0.0164
0
0.4852
0.4851
0.0284
0
0.7383
0.7383

0.6362
0.6362
0.6362
0.6362
0.6396
0.6396
0.6396
0.6396
0.6503
0.6503
0.6503
0.6503
0.6658
0.6658
0.6658
0.6658

ˆ C (SE)
AU
Unweighted
Weighted
0.6375 (0.0024)
0.6376 (0.0024)
0.6374 (0.0024)
0.6375 (0.0024)
0.6364 (0.0024)
0.6383 (0.0024)
0.6265 (0.0024)
0.6383 (0.0024)
0.6350 (0.0024)
0.6351 (0.0024)
0.6348 (0.0024)
0.6346 (0.0024)
0.6305 (0.0026)
0.6398 (0.0023)
0.6307 (0.0026)
0.6398 (0.0023)
0.6365 (0.0025)
0.6364 (0.0026)
0.6364 (0.0025)
0.6352 (0.0026)
0.6231 (0.0030)
0.6516 (0.0022)
0.6231 (0.0029)
0.6517 (0.0022)
0.6322 (0.0024)
0.6320 (0.0025)
0.6321 (0.0023)
0.6292 (0.0025)
0.6080 (0.0028)
0.6642 (0.0020)
0.6077 (0.0027)
0.6643 (0.0020)

Table C.1: Binary matching variable: Estimates (standard error) of AUC, β, γ, comparing logistic regression regression (LR), conditional logistic regression (CLR) and
proposed methods (Two-stage and Simultaneous). AUC estimates using naive and
weighted estimators are compared. Results based on 250 matched case control pairs
and δ = 0.
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Model

β

γ

δ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.75
0.75

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0.5018
0.4995
0.4995
0.5018
0.5034
0.5071
0.5071
0.5034
0.4880
0.4944
0.4944
0.4880
0.4995
0.5015
0.5015
0.4995

-0.2410
0
-0.0091
-0.0103
-0.2353
0
0.2317
0.2334
-0.2157
0
0.4911
0.4942
-0.2216
0
0.7241
0.7246

0.6396
0.6396
0.6396
0.6396
0.6503
0.6503
0.6503
0.6503
0.6658
0.6658
0.6658
0.6658
0.6855
0.6855
0.6855
0.6855

ˆ C (SE)
AU
Unweighted
Weighted
0.6350 (0.0024)
0.6351 (0.0024)
0.6313 (0.0023)
0.6386 (0.0023)
0.6305 (0.0026)
0.6398 (0.0023)
0.6307 (0.0026)
0.6398 (0.0023)
0.6365 (0.0025)
0.6364 (0.0026)
0.6330 (0.0025)
0.6469 (0.0025)
0.6231 (0.0030)
0.6516 (0.0022)
0.6231 (0.0029)
0.6517 (0.0022)
0.6322 (0.0024)
0.6320 (0.0025)
0.6294 (0.0023)
0.6492 (0.0023)
0.6080 (0.0028)
0.6642 (0.0020)
0.6077 (0.0027)
0.6643 (0.0020)
0.6348 (0.0024)
0.6351 (0.0026)
0.6321 (0.0023)
0.6582 (0.0026)
0.6026 (0.0026)
0.6859 (0.0019)
0.6025 (0.0026)
0.6860 (0.0019)

Table C.2: Binary matching variable: Estimates (standard error) of AUC, β, γ, comparing logistic regression regression (LR), conditional logistic regression (CLR) and
proposed methods (Two-stage and Simultaneous). AUC estimates using naive and
weighted estimators are compared. Results based on 250 matched case control pairs
and δ = 0.5.
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Model

β

γ

δ

β̂

γ̂

AUC

LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous
LR
CLR
Two-stage
Simultaneous

0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

0
0
0
0
0.25
0.25
0.25
0.25
0.5
0.5
0.5
0.5
0.75
0.75
0.75
0.75

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

0.5034
0.5071
0.5071
0.5034
0.4935
0.4972
0.4972
0.4935
0.5004
0.4960
0.4960
0.5004
0.4923
0.4903
0.4903
0.4923

-0.4870
0
-0.0219
-0.0183
-0.4738
0
0.2345
0.2377
-0.4679
0
0.4835
0.4792
-0.4573
0
0.7418
0.7398

0.6503
0.6503
0.6503
0.6503
0.6664
0.6664
0.6664
0.6664
0.6852
0.6852
0.6852
0.6852
0.7063
0.7063
0.7063
0.7063

ˆ C (SE)
AU
Unweighted
Weighted
0.6365 (0.0025)
0.6364 (0.0026)
0.6229 (0.0023)
0.6501 (0.0023)
0.6231 (0.0030)
0.6516 (0.0022)
0.6231 (0.0029)
0.6517 (0.0022)
0.6341 (0.0029)
0.6339 (0.0029)
0.6216 (0.0026)
0.6614 (0.0026)
0.6098 (0.0033)
0.6660 (0.0023)
0.6097 (0.0033)
0.6660 (0.0023)
0.6346 (0.0025)
0.6343 (0.0026)
0.6240 (0.0023)
0.6746 (0.0023)
0.6026 (0.0027)
0.6858 (0.0019)
0.6029 (0.0027)
0.6858 (0.0019)
0.6334 (0.0024)
0.6337 (0.0026)
0.6236 (0.0022)
0.6853 (0.0022)
0.5953 (0.0024)
0.7060 (0.0016)
0.5955 (0.0024)
0.7062 (0.0016)

Table C.3: Binary matching variable: Estimates (standard error) of AUC, β, γ, comparing logistic regression regression (LR), conditional logistic regression (CLR) and
proposed methods (Two-stage and Simultaneous). AUC estimates using naive and
weighted estimators are compared. Results based on 250 matched case control pairs
and δ = 1.0.
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AUC
n=250 matched pairs
1a. LR−Weighted

1b. LR−Unweighted

2a. CLR−Weighted

2b. CLR−Unweighted

0.00
−0.04
−0.08
−0.12

0.00

Bias in estimate of AUC

−0.04
−0.08

factor(delta)
−0.12

0
3a. Two stage−Weighted

3b. Two stage−Unweighted

0.5

0.00

1

−0.04
−0.08
−0.12
4a. Simultaneous−Weighted

4b. Simultaneous−Unweighted

0.00
−0.04
−0.08
−0.12
0.0

0.2

0.4

0.6

0.8

0.0

0.2

0.4

0.6

0.8

γ

Figure C.1. Binary matching variable: Comparison of bias between weighted and
naive approaches, when parameter estimates are based on logistic regression (LR),
conditional logistic regression (CLR) and the proposed procedures (Two-stage and
Simultaneous). We assume that the matched case control study is of size 250 matched
pairs.

109

Estimating β [n=250 matched pairs]
1. LR

2. CLR

3. Two−stage

4. Simultaneous

Bias in estimate of β

0.1

factor(delta)
0
0.0

0.5
1

−0.1

0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8

γ

Figure C.2. Binary matching variable: Comparison of bias between β estimates
from logistic regression (LR), conditional logistic regression (CLR) and the proposed
procedures (Two-stage and Simultaneous). We assume that the matched case control
study is of size 250 matched pairs.
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Estimating γ [n=250 matched pairs]
1. LR

2. CLR

3. Two−stage

4. Simultaneous

0.0

Bias in estimate of γ

−0.4

factor(delta)
0
0.5
1

−0.8

−1.2

0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8 0.0 0.2 0.4 0.6 0.8

γ

Figure C.3. Binary matching variable: Comparison of bias between γ estimates
from logistic regression (LR), conditional logistic regression (CLR) and the proposed
procedures (Two-stage and Simultaneous). We assume that the matched case control
study is of size 250 matched pairs.
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APPENDIX D
ESTIMATING THE STANDARD DEVIATION OF THE
WEIGHTED AUC ESTIMATOR

In Section 2.2.5, we describe a bootstrap sampling approach to estimate the standard error associated with the proposed weighted AUC estimate. To evaluate its
performance, 500 independent datasets of n = 100 matched case control pairs were
sampled from 500 independent cohort datasets simulated according to the algorithm
described in Section 2.3.1. We assumed that the matching variable Z is continuous,
ρ = 0.35, β = 0.5, γ = 0.5. Weighted AUC estimates were calculated according to
the Two-stage procedure described in Section 2.2. The standard deviation of the 500
independent AUC estimates was 0.027. From each of the 500 independent datasets,
we obtained a bootstrap estimate of the standard deviation as follows:

For the ith dataset (i = 1, · · · , 500):
1. Using the the full cohort dataset from which the ith matched dataset is sampled,
estimate the offset f (Z) and stratum specific weights w.
2. Obtain 250 bootstrap datasets, each of size n = 100 matched pairs obtained by
sampling the matched pairs with replacement. In each of the b = 1, · · · , 250
bootstrapped datasets:
(a) β, α, γ are estimated according to the Two-stage procedure.
(b) Weighted AUC estimates are calculated using the bootstrap sample derived
estimates of β, α, γ . We note that the offset f (Z) and stratum specific
weights are estimated once for each ith matched case control dataset.
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3. Obtain the standard deviation (SD) of the 250 weighted AUC estimates, denoted
d
by SDi (AUC).
The distribution of the 500 bootstrap estimates of standard deviation
d · · · , SD500 (AUC))
d is shown in Appendix Figure d.1. The median (IQR)
(SD1 (AUC),
of the 500 bootstrap estimates of SD was 0.023 (0.020 - 0.028), which are in close
agreement with the SD estimate of 0.027 from the 500 independent datasets.
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60
40
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20

Frequency

0.02

0.03

0.04

0.05

Bootstrap estimates of SD

Figure D.1. Bootstrap estimates of SD: Comparing the distribution of 500 bootstrap
estimates of SD of the weighted AUC estimator to the SD of the weighted AUC
estimates obtained from 500 independent datasets (blue, solid line). The 25th and
75th percentiles of the 500 bootstrap SD estimates as shown by the dashed, red lines.
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